Pathogenicity and virulence of Aspergillus fumigatus

References

• Who.int. ‘The top 10 causes of death’ [online]. 2022. Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death
   Google Scholar
• Bongomin F, Gago S, Oladele R, et al. Global and multi-national prevalence of fungal diseases—estimate precision. J Fungi. 2017;3(4):57.
   Web of Science ®Google Scholar
• Guinn K, Rubin E, Darwin KH. Tuberculosis: just the FAQs. MBio. 2017;8(6). DOI:10.1128/mBio.01910-17
   PubMed Web of Science ®Google Scholar
• Paget J, Spreeuwenberg P, Charu V, et al. Global mortality associated with seasonal influenza epidemics: new burden estimates and predictors from the GLaMORproject. J Glob Health. 2019;9(2). DOI:10.7189/jogh.09.020421
   PubMed Web of Science ®Google Scholar
• Rokas A. Aspergillus. Curr Biol. 2013;23(5):R187–35.
   PubMed Web of Science ®Google Scholar
• van de Veerdonk FL, Gresnigt MS, Romani L, et al. Aspergillus fumigatus morphology and dynamic host interactions. Nature Rev Microbiol. 2017;15(11):661–674.
   PubMed Web of Science ®Google Scholar
• O’gorman C. Airborne Aspergillus fumigatus conidia: a risk factor for aspergillosis. Fungal Biol Rev. 2011;25(3):151–157.
   Google Scholar
• Sugui J, Kwon-Chung K, Juvvadi P, et al. Aspergillus fumigatus and related species. Cold Spring Harb Perspect Med. 2014;5(2):a019786.
   PubMed Web of Science ®Google Scholar
• Sales-Campos H, Tonani L, Cardoso C, et al. The immune interplay between the host and the pathogen in Aspergillus fumigatus lung infection. Bio Med Res Int. 2013;2013:1–14.
   Google Scholar
• Valiante V, Macheleidt J, Föge M. The Aspergillus fumigatus cell wall integrity signaling pathway: drug target, compensatory pathways, and virulence. Front Microbiol. 2015;06. DOI:10.3389/fmicb.2015.00325.
   Google Scholar
• Shepardson K, Ngo L, Aimanianda V, et al. Hypoxia enhances innate immune activation to Aspergillus fumigatus through cell wall modulation. Microbes Infect. 2013;15(4):259–269.
   PubMed Web of Science ®Google Scholar
• Kwon-Chung KJ, Sugui JA. What do we know about the role of gliotoxin in the pathobiology of Aspergillus fumigatus? Med Mycol. 2009;47(Suppl 1):S97–103.
   PubMed Web of Science ®Google Scholar
• Dyer P, O’gorman C. Sexual development and cryptic sexuality in fungi: insights from Aspergillus species. FEMS Microbiol Rev. 2012;36(1):165–192.
   PubMed Web of Science ®Google Scholar
• Latge J, Chamilos G. Aspergillus fumigatus and Aspergillosis in 2019. Clinical Microbiology Reviews. 2019;33(1):199.
   Web of Science ®Google Scholar
• Hasleton PS. The internal surface area of the adult human lung. J Anat. 1972;112(Pt 3): 391–400. PMID: 4564685.
   PubMedGoogle Scholar
• Hospenthal DR, Kwon-Chung KJ, Bennett JE. Concentrations of airborne Aspergillus compared to the incidence of invasive aspergillosis: lack of correlation. Med Mycol. 1998;36(3):165–168.
   PubMed Web of Science ®Google Scholar
• Hoselton S, Samarasinghe A, Seydel J, et al. An inhalation model of airway allergic response to inhalation of environmental Aspergillus fumigatus conidia in sensitized BALB/c mice. Med Mycol. 2010;48(8):1056–1065.
   PubMed Web of Science ®Google Scholar
• Baltussen T, Zoll J, Verweij P, et al. Molecular mechanisms of conidial germination in Aspergillus spp. Microbiol Mol Biol Rev. 2020;84(1). DOI:10.1128/MMBR.00049-19
   PubMed Web of Science ®Google Scholar
• Dagenais T, Keller N. Pathogenesis of Aspergillus fumigatus in Invasive Aspergillosis. Clinical Microbiology Reviews. 2009;22(3):447–465.
   PubMed Web of Science ®Google Scholar
• Rosowski E, Raffa N, Knox B, et al. Macrophages inhibit Aspergillus fumigatus germination and neutrophil-mediated fungal killing. PLOS Pathogens. 2018;14(8):e1007229.
   PubMed Web of Science ®Google Scholar
• Osherov N, May G. The molecular mechanisms of conidial germination. FEMS Microbiol Lett. 2001;199(2):153–160.
   PubMed Web of Science ®Google Scholar
• Sephton-Clark P, Voelz K. Spore germination of pathogenic filamentous fungi. Adv Appl Microbiol. 2018;117–157. DOI:10.1016/bs.aambs.2017.10.002
   PubMed Web of Science ®Google Scholar
• Kwon-Chung KJ, Sugui JA, Heitman J. Aspergillus fumigatus—what makes the species a ubiquitous human fungal pathogen? PLOS Pathogens. 2013;9(12):e1003743.
   PubMed Web of Science ®Google Scholar
• Lamarre C, Sokol S, Debeaupuis J, et al. Transcriptomic analysis of the exit from dormancy of Aspergillus fumigatus conidia. BMC Genomics. 2008;9(1). DOI:10.1186/1471-2164-9-417
   PubMedGoogle Scholar
• Wang F, Sethiya P, Hu X, et al. Transcription in fungal conidia before dormancy produces phenotypically variable conidia that maximize survival in different environments. Nat Microbiol. 2021;6(8):1066–1081.
   PubMed Web of Science ®Google Scholar
• Hagiwara D, Takahashi H, Kusuya Y, et al. Comparative transcriptome analysis revealing dormant conidia and germination associated genes in Aspergillus species: an essential role for AtfA in conidial dormancy. BMC Genomics. 2016;17(1). DOI:10.1186/s12864-016-2689-z
   PubMedGoogle Scholar
• Guinea J, Torres-Narbona M, Gijón P, et al. Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin Microbiol Infect. 2010;16(7):870–877.
   PubMed Web of Science ®Google Scholar
• Chen J, Yang Q, Huang J, et al. Risk factors for invasive pulmonary Aspergillosis and hospital mortality in acute-on-chronic liver failure patients: a retrospective-cohort study. Int J Med Sci. 2013;10(12):1625–1631.
   PubMed Web of Science ®Google Scholar
• Denning D, Pashley C, Hartl D, et al. Fungal allergy in asthma–state of the art and research needs. Clin Transl Allergy. 2014;4(1):14.
   PubMedGoogle Scholar
• Kousha M, Tadi R, Soubani A. Pulmonary aspergillosis: a clinical review. Eur Respir Rev. 2011;20(121):156–174.
   PubMedGoogle Scholar
• Cuenca-Estrella M, Bassetti M, Lass-Florl C, et al. Detection and investigation of invasive mould disease. J Antimicrob Chemother. 2010;66(Supplement 1):i15–24.
   PubMedGoogle Scholar
• Kosmidis C, Denning D. The clinical spectrum of pulmonary aspergillosis. Thorax. 2014;70(3):270–277.
   PubMed Web of Science ®Google Scholar
• Denning D, Cadranel J, Beigelman-Aubry C, et al. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. Eur Respir J. 2015;47(1):45–68.
   Web of Science ®Google Scholar
• Warn P, Sharp A, Morrissey G, et al. Activity of aminocandin (IP960; HMR3270) compared with amphotericin B, itraconazole, caspofungin and micafungin in neutropenic murine models of disseminated infection caused by itraconazole-susceptible and -resistant strains of Aspergillus fumigatus. Int J Antimicrob Agents. 2010;35(2):146–151.
   PubMed Web of Science ®Google Scholar
• Egerer G, Reichert D, Pletz M, et al. Caspofungin for treatment of invasive aspergillosis in Germany: results of a pre-planned subanalysis of an international registry. Eur J Med Res. 2012;17(1). DOI:10.1186/2047-783X-17-7
   PubMedGoogle Scholar
• Patterson T, Thompson G, Denning D, et al. Practice guidelines for the diagnosis and management of Aspergillosis: 2016 update by the infectious diseases society of America. Clinl Infect Dis. 2016;63(4):e1–60.
   PubMed Web of Science ®Google Scholar
• Maghrabi F, Denning D. The management of chronic pulmonary Aspergillosis: the UK national aspergillosis centre approach. Current Fungal Infection Reports. 2017;11(4):242–251.
   PubMedGoogle Scholar
• Jenks J, Hoenigl M. Treatment of Aspergillosis. J Fungi. 2018;4(3):98.
   Web of Science ®Google Scholar
• Pegorie M, Denning D, Welfare W. Estimating the burden of invasive and serious fungal disease in the United Kingdom. J Infect. 2017;74(1):60–71.
   PubMed Web of Science ®Google Scholar
• Benedict K, Jackson B, Chiller T, et al. Estimation of direct healthcare costs of fungal diseases in the United States. Clinl Infect Dis. 2018;68(11):1791–1797.
   Web of Science ®Google Scholar
• Sabino R, Veríssimo C, Viegas C, et al. The role of occupational Aspergillus exposure in the development of diseases. Med Mycol. 2019;57(Supplement_2):S196–205.
   PubMedGoogle Scholar
• Sharma O, Chwogule R. Many faces of pulmonary aspergillosis. Eur Respir J. 1998;12(3):705–715.
   PubMed Web of Science ®Google Scholar
• Kontoyiannis D, Selleslag D, Mullane K, et al. Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial. J Antimicrob Chemother. 2017;73(3):757–763.
   Web of Science ®Google Scholar
• Gerson S. Prolonged granulocytopenia: the major risk factor for invasive pulmonary Aspergillosis in Patients with Acute Leukemia. Ann internal med. 1984;100(3):345.
   PubMed Web of Science ®Google Scholar
• Reichenberger F, Habicht J, Gratwohl A, et al. Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients. Eur Respir J. 2001;19(4):743–755.
   Web of Science ®Google Scholar
• Cunha C, Kurzai O, Löffler J, et al. Neutrophil responses to aspergillosis: new roles for old players. Mycopathologia. 2014;178(5–6):387–393.
   PubMed Web of Science ®Google Scholar
• Gago S, Overton N, Ben-Ghazzi N, et al. Lung colonization by Aspergillus fumigatus is controlled by ZNF77. Nat Commun. 2018;9(1). DOI:10.1038/s41467-018-06148-7
   PubMedGoogle Scholar
• Bazaz R, Denning D. Aspergillosis: causes, types and treatment. Pharm J. 2019. DOI:10.1211/PJ.2019.20206738
   Google Scholar
• De Pauw B, Walsh T, Donnelly J, et al. Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases Mycoses Study Group (EORTC/MSG) consensus group. Clinl Infect Dis. 2008;46(12):1813–1821.
   PubMed Web of Science ®Google Scholar
• Hammond E, McDonald C, Vestbo J, et al. The global impact of Aspergillus infection on COPD. BMC Pulm Med. 2020;20(1). DOI:10.1186/s12890-020-01259-8
   PubMed Web of Science ®Google Scholar
• Lin S, Schranz J, Teutsch S. Aspergillosis case-fatality rate: systematic review of the literature. Clinl Infect Dis. 2001;32(3):358–366.
   PubMed Web of Science ®Google Scholar
• Baddley J, Andes D, Marr K, et al. Factors associated with mortality in transplant patients with invasive Aspergillosis. Clinl Infect Dis. 2010;50(12):1559–1567.
   PubMed Web of Science ®Google Scholar
• Sun K, Tsai C, Chen S, et al. Clinical outcome and prognostic factors associated with invasive pulmonary aspergillosis: an 11-year follow-up report from Taiwan. PLoS ONE. 2017;12(10):e0186422.
   PubMed Web of Science ®Google Scholar
• Palmer L, Greenberg H, Schiff M. Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease. Thorax. 1991;46(1):15–20.
   PubMed Web of Science ®Google Scholar
• Singh N, Avery R, Munoz P, et al. Trends in risk profiles for and mortality associated with invasive Aspergillosis among liver transplant recipients. Clinl Infect Dis. 2003;36(1):46–52.
   PubMed Web of Science ®Google Scholar
• Mühlemann K, Wenger C, Zenhäusern R, et al. Risk factors for invasive aspergillosis in neutropenic patients with hematologic malignancies. Leukemia. 2005;19(4):545–550.
   PubMed Web of Science ®Google Scholar
• Husain S, Camargo J. Invasive Aspergillosis in solid‐organ transplant recipients: guidelines from the American Society of transplantation infectious diseases community of practice. Clin Transplant. 2019;33(9). DOI:10.1111/ctr.13544
   Web of Science ®Google Scholar
• Liu L, Gu Y, Wang Y, et al. The clinical characteristics of patients with nonneutropenic invasive pulmonary Aspergillosis. Front Med (Lausanne). 2021;8. DOI:10.3389/fmed.2021.631461
   Web of Science ®Google Scholar
• Meersseman W, Lagrou K, Maertens J, et al. Invasive Aspergillosis in the intensive care unit. Clinl Infect Dis. 2007;45(2):205–216.
   PubMed Web of Science ®Google Scholar
• Mercier T, Dunbar A, Veldhuizen V, et al. Point of care aspergillus testing in intensive care patients. crit care. 2020;24(1). DOI:10.1186/s13054-020-03367-7
   PubMed Web of Science ®Google Scholar
• Naaraayan A, Kavian R, Lederman J, et al. Invasive pulmonary aspergillosis – case report and review of literature. J Community Hosp Intern Med Perspect. 2015;5(1):26322.
   PubMedGoogle Scholar
• Georgiadou S, Sipsas N, Marom E, et al. The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts. Clinl Infect Dis. 2011;52(9):1144–1155.
   PubMed Web of Science ®Google Scholar
• Shroff S, Shroff G, Yust‐katz S, et al. The CT halo sign in invasive aspergillosis. Clin Case Rep. 2014;2(3):113–114.
   PubMedGoogle Scholar
• Blum U, Windfuhr M, Buitrago-Tellez C, et al. Invasive Pulmonary Aspergillosis. Chest. 1994;106(4):1156–1161.
   PubMedGoogle Scholar
• Won H, Lee K, Cheon J, et al. Invasive pulmonary aspergillosis: prediction at thin-section CT in patients with neutropenia–a prospective study. Radiology. 1998;208(3):777–782.
   PubMed Web of Science ®Google Scholar
• Raveendran S, Lu Z. CT findings and differential diagnosis in adults with invasive pulmonary aspergillosis. Radiol Infect Dis. 2018;5(1):14–25.
   Google Scholar
• Li X, Zeng X, Liu B, et al. COVID-19 Infection Presenting with CT halo sign. Radiology. 2020;2(1):e200026.
   PubMed Web of Science ®Google Scholar
• Adzic N, Obradovic K, Urban V, et al. Computed tomography features of pulmonary metastases from angiosarcoma: lessons learned from one case study. Radiol Case Rep. 2021;16(9):2646–2650.
   PubMedGoogle Scholar
• Lee Y, Choi Y, Lee K, et al. CT halo sign: the spectrum of pulmonary diseases. Br J Radiol. 2005;78(933):862–865.
   PubMed Web of Science ®Google Scholar
• Shelhamer J. The laboratory evaluation of opportunistic pulmonary infections. Ann internal med. 1996;124(6):585.
   PubMed Web of Science ®Google Scholar
• Luong M, Clancy C, Vadnerkar A, et al. Comparison of an Aspergillus real-time polymerase chain reaction assay with galactomannan testing of bronchoalvelolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in lung transplant recipients. Clinl Infect Dis. 2011;52(10):1218–1226.
   PubMed Web of Science ®Google Scholar
• Zhou W, Li H, Zhang Y, et al. Diagnostic Value of galactomannan antigen test in serum and bronchoalveolar lavage fluid samples from patients with nonneutropenic invasive pulmonary Aspergillosis. J Clin Microbiol. 2017;55(7):2153–2161.
   PubMed Web of Science ®Google Scholar
• Herbrecht R, Denning D, Patterson T, et al. Voriconazole versus amphotericin B for primary therapy of invasive Aspergillosis. N Engl J Med. 2002;347(6):408–415.
   PubMed Web of Science ®Google Scholar
• Singh N, Husain S. Aspergillosis in solid organ transplantation. Am J Transplant. 2013;13(s4):228–241.
   PubMedGoogle Scholar
• Lilly C, Welch V, Mayer T, et al. Evaluation of intravenous voriconazole in patients with compromised renal function. BMC Infect Dis. 2013;13(1). DOI:10.1186/1471-2334-13-14
   PubMedGoogle Scholar
• Izumikawa K, Tashiro T, Tashiro M, et al. Pathogenesis and clinical features of chronic pulmonary aspergillosis – is it possible to distinguish CNPA and CCPA clinically? J Infect Chemother. 2014;20(3):208–212.
   PubMed Web of Science ®Google Scholar
• Gaffi.org. [online]. 2022. Available from: https://gaffi.org/wp-content/uploads/Briefing-note-TB-and-CPA-September-2021.pdf.
   Google Scholar
• Smith N, Denning D. Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma. Eur Respir J. 2010;37(4):865–872.
   PubMed Web of Science ®Google Scholar
• Schweer K, Bangard C, Hekmat K, et al. Chronic pulmonary aspergillosis. Mycoses. 2013;57(5):257–270.
   PubMed Web of Science ®Google Scholar
• Medicine TLR. Chronic pulmonary aspergillosis: help is on the way. Lancet Respir Med. 2016;4(2):83.
   PubMed Web of Science ®Google Scholar
• Judson MA, Stevens DA. The treatment of pulmonary aspergilloma. Curr Opin Invest Drugs. 2001;2(10): 1375–1377. PMID: 11890350.
   PubMedGoogle Scholar
• Jain L, Denning D. The efficacy and tolerability of voriconazole in the treatment of chronic cavitary pulmonary aspergillosis. J Infect. 2006;52(5):e133–137.
   PubMedGoogle Scholar
• Agarwal R, Vishwanath G, Aggarwal A, et al. Itraconazole in chronic cavitary pulmonary aspergillosis: a randomised controlled trial and systematic review of literature. Mycoses. 2013;56(5):559–570.
   PubMed Web of Science ®Google Scholar
• Bongomin F, Harris C, Hayes G, et al. Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis. PLoS ONE. 2018;13(4):e0193732.
   PubMed Web of Science ®Google Scholar
• Farid S, Mohamed S, Devbhandari M, et al. Results of surgery for chronic pulmonary Aspergillosis, optimal antifungal therapy and proposed high risk factors for recurrence - a national centre’s experience. J Cardiothorac Surg. 2013;8(1). DOI:10.1186/1749-8090-8-180
   PubMedGoogle Scholar
• Al-Shair K, Atherton G, Harris C, et al. Long-term antifungal treatment improves health status in patients with chronic pulmonary Aspergillosis: a longitudinal analysis. Clinl Infect Dis. 2013;57(6):828–835.
   PubMed Web of Science ®Google Scholar
• Shah A, Panjabi C. Allergic Bronchopulmonary Aspergillosis: a perplexing clinical entity. Allergy, Asthma & Immunology Research. 2016;8(4):282.
   PubMed Web of Science ®Google Scholar
• Janahi I, Rehman A, Al-Naimi A. Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Ann Thorac Med. 2017;12(2):74.
   PubMed Web of Science ®Google Scholar
• Maturu V, Agarwal R. Prevalence of Aspergillus sensitization and allergic bronchopulmonary aspergillosis in cystic fibrosis: systematic review and meta-analysis. Clinical & Clinical & Experimental Allergy. 2015;45(12):1765–1778.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Sehgal I, Dhooria S, et al. Developments in the diagnosis and treatment of allergic bronchopulmonary aspergillosis. Expert Rev Respir Med. 2016;10(12):1317–1334.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Hazarika B, Gupta D, et al. Aspergillus hypersensitivity in patients with chronic obstructive pulmonary disease: cOPD as a risk factor for ABPA? Med Mycol. 2010;48(7):988–994.
   PubMed Web of Science ®Google Scholar
• Tiew P, Ko F, Pang S, et al. Environmental fungal sensitisation associates with poorer clinical outcomes in COPD. Eur Respir J. 2020;56(2):2000418.
   PubMed Web of Science ®Google Scholar
• Shah A. Allergic bronchopulmonary aspergillosis: an Indian perspective. Curr Opin Pulm Med. 2007;13(1):72–80.
   PubMed Web of Science ®Google Scholar
• Asano K, Hebisawa A, Ishiguro T, et al. New clinical diagnostic criteria for allergic bronchopulmonary aspergillosis/mycosis and its validation. J Allergy Clin Immunol. 2021;147(4):1261–1268.e5.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Khan A, Garg M, et al. Pictorial essay: allergic bronchopulmonary aspergillosis. Indian J Radiol Imaging. 2011;21(04):242–252.
   PubMedGoogle Scholar
• Fink JN. Therapy of allergic bronchopulmonary aspergillosis. The Indian Journal of Chest Diseases & Allied Sciences. 2000;42(4): 221–224. PMID: 15597668.
   PubMedGoogle Scholar
• Greenberger P. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol. 2002;110(5):685–692.
   PubMed Web of Science ®Google Scholar
• Lehmann S, Pfannenstiel C, Friedrichs F, et al. Omalizumab: a new treatment option for allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Ther Adv Respir Dis. 2014;8(5):141–149.
   PubMed Web of Science ®Google Scholar
• Fraczek M, Chishimba L, Niven R, et al. Corticosteroid treatment is associated with increased filamentous fungal burden in allergic fungal disease. J Allergy Clin Immunol. 2018;142(2):407–414.
   PubMed Web of Science ®Google Scholar
• Elphick H, Southern K. Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis. Cochrane Database Syst Rev. 2016;2016(11). DOI:10.1002/14651858.CD002204.pub4
   Google Scholar
• Aaron S, Vandemheen K, Freitag A, et al. Treatment of Aspergillus fumigatus in patients with cystic fibrosis: a randomized, placebo-controlled pilot study. PLoS ONE. 2012;7(4):e36077.
   PubMed Web of Science ®Google Scholar
• Chishimba L, Niven R, Cooley J, et al. Voriconazole and posaconazole improve asthma severity in allergic Bronchopulmonary Aspergillosis and severe asthma with fungal sensitization. J Asthma. 2012;49(4):423–433.
   PubMed Web of Science ®Google Scholar
• Kanu A, Patel K. Treatment of allergic bronchopulmonary aspergillosis (ABPA) in CF with anti‐ige antibody (omalizumab). Pediatr Pulmonol. 2008;43(12):1249–1251.
   PubMed Web of Science ®Google Scholar
• Emiralioglu N, Dogru D, Tugcu G, et al. Omalizumab treatment for Allergic Bronchopulmonary Aspergillosis in cystic fibrosis. Ann Pharmacother. 2015;50(3):188–193.
   PubMed Web of Science ®Google Scholar
• Collins J, Hudes DV, Rosenstreich D. Allergic bronchopulmonary aspergillosis treated successfully for one year with omalizumab. J Asthma Allergy. 2012;65. DOI:10.2147/JAA.S34579
   PubMedGoogle Scholar
• Koutsokera A, Corriveau S, Sykes J, et al. Omalizumab for asthma and allergic bronchopulmonary aspergillosis in adults with cystic fibrosis. J Cystic Fibrosis. 2020;19(1):119–124.
   PubMed Web of Science ®Google Scholar
• Chrdle A, Mustakim S, Bright-Thomas R, et al. Aspergillus bronchitis without significant immunocompromise. Ann N Y Acad Sci. 2012;1272(1):73–85.
   PubMedGoogle Scholar
• Brandt C, Roehmel J, Rickerts V, et al. Aspergillus Bronchitis in Patients with Cystic Fibrosis. Mycopathologia. 2017;183(1):61–69.
   PubMed Web of Science ®Google Scholar
• Shoseyov D, Brownlee K, Conway S, et al. Aspergillus Bronchitis in Cystic Fibrosis. Chest. 2006;130(1):222–226.
   PubMed Web of Science ®Google Scholar
• Coughlan C, Chotirmall S, Renwick J, et al. The effect of Aspergillus fumigatus Infection on Vitamin D receptor expression in cystic fibrosis. Am J Respir Crit Care Med. 2012;186(10):999–1007.
   PubMed Web of Science ®Google Scholar
• Banerjee B, Greenberger PA, Fink JN, et al. Immunological characterization of Asp f 2, a major allergen from Aspergillus fumigatus associated with allergic bronchopulmonary aspergillosis. Infect Immun. 1998;66(11):5175–5182.
   PubMed Web of Science ®Google Scholar
• Levdansky E, Romano J, Shadkchan Y, et al. Coding tandem repeats generate diversity in Aspergillus fumigatus genes. Eukaryot Cell. 2007;6(8):13801391. PubMed: 17557878.
   Google Scholar
• Upadhyay SK, Mahajan L, Ramjee S, et al. Identification and characterization of a laminin-binding protein of Aspergillus fumigatus: extracellular thaumatin domain protein (AfCalap). J Med Microbiol. 2009;58(6):714–722.
   PubMed Web of Science ®Google Scholar
• Speth C, Rambach G, Lass-Flörl C, et al. Galactosaminogalactan (GAG) and its multiple roles in Aspergillus pathogenesis. Virulence. 2019;10(1):976–983.
   PubMed Web of Science ®Google Scholar
• Wagener J, Echtenacher B, Rohde M, et al. The putative alpha-1,2-mannosyltransferase AfMnt1 of the opportunistic fungal pathogen Aspergillus fumigatus is required for cell wall stability and full virulence. Eukaryot Cell. 2008;7(10):1661–1673.
   PubMedGoogle Scholar
• Bhabhra R, Miley MD, Mylonakis E, et al. Disruption of the Aspergillus fumigatus gene encoding nucleolar protein CgrA impairs thermotolerant growth and reduces virulence. Infect Immun. 2004 Aug;72(8):4731–4740. DOI:10.1128/IAI.72.8.4731-4740.2004.
   PubMed Web of Science ®Google Scholar
• Kolattukudy PE, Lee JD, Rogers LM, et al. Evidence for possible involvement of an elastolytic serine protease in aspergillosis. Infect Immun. 1993;61(6):2357–2368.
   PubMed Web of Science ®Google Scholar
• Beattie SR, Mark KMK, Thammahong A, et al. Filamentous fungal carbon catabolite repression supports metabolic plasticity and stress responses essential for disease progression. PLoS Pathogen. 2017;13(4):e1006340.
   PubMed Web of Science ®Google Scholar
• Panepinto JC, Oliver BG, Fortwendel JR, et al. Deletion of the Aspergillus fumigatus gene encoding the Ras-related protein RhbA reduces virulence in a model of invasive pulmonary aspergillosis. Infect Immun. 2003;71(5):2819–2826.
   PubMed Web of Science ®Google Scholar
• Krappmann S, Bignell EM, Reichard U, et al. The Aspergillus fumigatus transcriptional activator CpcA contributes significantly to the virulence of this fungal pathogen. Mol Microbiol. 2004;52(3):785–799.
   PubMed Web of Science ®Google Scholar
• Amich J, Bignell E. Amino acid biosynthetic routes as drug targets for pulmonary fungal pathogens: what is known and why do we need to know more? Curr Opin Microbiol. 2016;32:151–158.
   PubMed Web of Science ®Google Scholar
• Kerkaert J, Le Mauff F, Wucher B, et al. An alanine aminotransferase is required for biofilm-specific resistance of Aspergillus fumigatus to Echinocandin Treatment. MBio. 2022;13(2). DOI:10.1128/mbio.02933-21
   PubMed Web of Science ®Google Scholar
• Liebmann B, Muller M, Braun A, et al. The cyclic AMP-dependent protein kinase a network regulates development and virulence in Aspergillus fumigatus. Infect Immun. 2004;72(9):5193–5203.
   PubMed Web of Science ®Google Scholar
• Schrettl M, Bignell E, Kragl C, et al. Siderophore biosynthesis but not reductive iron assimilation is essential for Aspergillus fumigatus virulence. J Exp Med. 2004;200(9):1213–1219.
   PubMed Web of Science ®Google Scholar
• Schrettl M, Haas H. Iron homeostasis–achilles’ heel of Aspergillus fumigatus? Curr Opin Microbiol. 2011;14(4):400–405.
   PubMed Web of Science ®Google Scholar
• Amich J, Vicente Franqueira R, Leal F, et al. Aspergillus fumigatus survival in alkaline and extreme zinc-limiting environments relies on the induction of a zinc homeostasis system encoded by the zrfc and aspf2 genes. Eukaryotic Cell. 2010;9(3):424–437.
   PubMedGoogle Scholar
• Moreno MÁ, Ibrahim-Granet O, Vicentefranqueira R, et al. The regulation of zinc homeostasis by the ZafA transcriptional activator is essential for Aspergillus fumigatus virulence. Mol Microbiol. 2007;64(5):1182–1197.
   PubMed Web of Science ®Google Scholar
• Schlachter CR, Klapper V, Radford T, et al. Comparative studies of aspergillus fumigatus 2-methylcitrate synthase and human citrate synthase. Biol Chem. 2019;400(12):1567–1581.
   PubMed Web of Science ®Google Scholar
• Brown JS, Aufauvre-Brown A, Brown J, et al. Signature-tagged and directed mutagenesis identify PABA synthetase as essential for aspergillus fumigatus pathogenicity. Mol Microbiol. 2002;36(6):1371–1380.
   Web of Science ®Google Scholar
• Mellado E, Aufauvre-Brown A, Gow NA, et al. The Aspergillus fumigatus chsC and chsG genes encode class III chitin synthases with different functions. Mol Microbiol. 1996;20(3):667–679.
   PubMed Web of Science ®Google Scholar
• Schmalhorst PS, Krappmann S, Vervecken W, et al. Contribution of galactofuranose to the virulence of the opportunistic pathogen Aspergillus fumigatus. Eukaryot Cell. 2008;7(8):1268–1277.
   PubMedGoogle Scholar
• Chamilos G, Carvalho A. Aspergillus fumigatus DHN-Melanin. Curr Top Microbiol Immunol. 2020;425:17–28.
   PubMed Web of Science ®Google Scholar
• Calera JA, Paris S, Monod M, et al. Cloning and disruption of the antigenic catalase gene of Aspergillus fumigatus’. Infect Immun. 1997;65(11):4718–4724.
   PubMed Web of Science ®Google Scholar
• Lambou K, Lamarre C, Beau R, et al. Functional analysis of the superoxide dismutase family in Aspergillus fumigatus. Mol Microbiol. 2010;75(4):910–923.
   PubMed Web of Science ®Google Scholar
• Ries LNA, Pardeshi L, Dong Z, et al. The Aspergillus fumigatus transcription factor RglT is important for gliotoxin biosynthesis and self-protection, and virulence. PLOS Pathog. 2020;16(7):e1008645.
   PubMed Web of Science ®Google Scholar
• Shlezinger N, Irmer H, Dhingra S, et al. Sterilizing immunity in the lung relies on targeting fungal apoptosis-like programmed cell death. Science. 2017;357(6355):1037–1041.
   PubMed Web of Science ®Google Scholar
• Zhao W, Panepinto JC, Fortwendel JR, et al. Deletion of the regulatory subunit of protein kinase a in Aspergillus fumigatus alters morphology, sensitivity to oxidative damage, and virulence. Infect Immun. 2006;74(8):4865–4874.
   PubMed Web of Science ®Google Scholar
• Dirr F, Echtenacher B, Heesemann J, et al. AfMkk2 is required for cell wall integrity signaling, adhesion, and full virulence of the human pathogen Aspergillus fumigatus. Int J Med Microbiol. 2010;300(7):496–502.
   PubMed Web of Science ®Google Scholar
• Winkelströter LK, Bom VL, de Castro PA, et al. High osmolarity glycerol response PtcB phosphatase is important for Aspergillus fumigatus virulence. Mol Microbiol. 2015;96(1):42–54.
   PubMed Web of Science ®Google Scholar
• Alves de Castro P, Dos Reis TF, Dolan SK, et al. The Aspergillus fumigatus SchA SCH9 kinase modulates SakA HOG1 MAP kinase activity and it is essential for virulence. Mol Microbiol. 2016 Nov;102(4):642–671. DOI:10.1111/mmi.13484.
   PubMed Web of Science ®Google Scholar
• Steinbach WJ, Cramer RA Jr, Perfect BZ, et al. Calcineurin controls growth, morphology, and pathogenicity in Aspergillus fumigatus. Eukaryot Cell. 2006;5(7):1091–1103.
   PubMedGoogle Scholar
• Soriani FM, Malavazi I, Da Silva Ferreira ME, et al. Functional characterization of the Aspergillus fumigatus CRZ1 homologue, CrzA. Mol Microbiol. 2008;67(6):1274–1291.
   PubMed Web of Science ®Google Scholar
• de Castro P, Colabardini A, Manfiolli A, et al. Aspergillus fumigatus calcium-responsive transcription factors regulate cell wall architecture promoting stress tolerance, virulence and caspofungin resistance. PLoS Genet. 2019;15(12):e1008551.
   PubMed Web of Science ®Google Scholar
• Willger SD, Puttikamonkul S, Kim KH, et al. A sterol-regulatory element binding protein is required for cell polarity, hypoxia adaptation, azole drug resistance, and virulence in Aspergillus fumigatus. PLOS Pathog. 2008;4(11):e1000200.
   PubMed Web of Science ®Google Scholar
• Kirkland M, Stannard M, Kowalski C, et al. Host lung environment limits Aspergillus fumigatus germination through an SskA-Dependent Signaling Response. mSphere. 2021;6(6). DOI:10.1128/msphere.00922-21
   PubMed Web of Science ®Google Scholar
• Kowalski C, Kerkaert J, Liu K, et al. Fungal biofilm morphology impacts hypoxia fitness and disease progression. Nat Microbiol. 2019;4(12):2430–2441.
   PubMed Web of Science ®Google Scholar
• Nizet V, Johnson R. Interdependence of hypoxic and innate immune responses. Nat Rev Immunol. 2009;9(9):609–617.
   PubMed Web of Science ®Google Scholar
• Feng X, Krishnan K, Richie DL, et al. Haca-independent functions of the ER stress sensor IREA synergize with the canonical upr to influence virulence traits in aspergillus fumigatus. PLOS Pathogens. 2011;7(10):10.
   Web of Science ®Google Scholar
• Mulder HJ, Saloheimo M, Penttilä M, et al. The transcription factor HACA mediates the unfolded protein response in aspergillus niger, and up-regulates its own transcription. Mol Genet Genomic. 2004;271(2):130–140.
   PubMed Web of Science ®Google Scholar
• Bertuzzi M, Schrettl M, Alcazar-Fuoli L, et al. The pH-responsive PacC transcription factor of Aspergillus fumigatus governs epithelial entry and tissue invasion during pulmonary aspergillosis. 16 PLOS Pathog. 2014;101:e1004413. 10.1371/journal.ppat.1004413
   PubMedGoogle Scholar
• Fortwendel JR, Zhao W, Bhabhra R, et al. A fungus-specific ras homolog contributes to the hyphal growth and virulence of aspergillus fumigatus. Eukaryotic Cell. 2005;4(12):1982–1989.
   PubMedGoogle Scholar
• Croft CA, Culibrk L, Moore MM, et al. Interactions of Aspergillus fumigatus conidia with airway epithelial cells: a Critical review. Front Microbiol. 2016;7:472.
   PubMed Web of Science ®Google Scholar
• Thau N, Monod M, Crestani B, et al. Rodletless mutants of Aspergillus fumigatus’. Infect Immun. 1994;62(10):4380–4388.
   PubMed Web of Science ®Google Scholar
• Valsecchi I, Dupres V, Stephen-Victor E, et al. Role of Hydrophobins in Aspergillus fumigatus. J Fungi. 2017;4(1):2.
   Web of Science ®Google Scholar
• Gravelat FN, Beauvais A, Liu H, et al. Aspergillus galactosaminogalactan mediates adherence to host constituents and conceals hyphal β-glucan from the immune system. PLOS Pathog. 2013;9(8):e1003575.
   PubMed Web of Science ®Google Scholar
• Lee MJ, Geller AM, Bamford NC, et al. Deacetylation of fungal exopolysaccharide mediates adhesion and biofilm formation. MBio. 2016;7(2): e00252-16. DOI:10.1128/mBio.00252-16
   Web of Science ®Google Scholar
• Kowalski C, Morelli K, Schultz D, et al. Fungal biofilm architecture produces hypoxic microenvironments that drive antifungal resistance. Proc Nat Acad Sci. 2020;117(36):22473–22483.
   PubMed Web of Science ®Google Scholar
• Di Piazza S, Houbraken J, Meijer M, et al. Thermotolerant and thermophilic mycobiota in different steps of compost maturation. Microorganisms. 2020;8(6):880.
   PubMed Web of Science ®Google Scholar
• Nierman WC, Pain A, Anderson MJ, et al. Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus. Nature. 2005;438(7071):1151–1156.
   PubMed Web of Science ®Google Scholar
• Do JH, Yamaguchi R, Miyano S. Exploring temporal transcription regulation structure of Aspergillus fumigatus in heat shock by state space model. BMC Genomics. 2009;10(1):306.
   PubMedGoogle Scholar
• Bhabhra R, Askew DS. Thermotolerance and virulence of Aspergillus fumigatus: role of the fungal nucleolus. Med Mycol. 2005;43(Supplement_1):S87–93.
   PubMedGoogle Scholar
• Fleck CB, Schöbel F, Brock M. Nutrient acquisition by pathogenic fungi: nutrient availability, pathway regulation, and differences in substrate utilization. Int J Med Microbiol. 2011;301(5):400–407.
   PubMed Web of Science ®Google Scholar
• Abad A, Fernández-Molina JV, Bikandi J, et al. What makes Aspergillus fumigatus a successful pathogen? Genes and molecules involved in invasive aspergillosis. Rev Iberoam Micol. 2010;27(4):155–182.
   PubMed Web of Science ®Google Scholar
• Perez-Cuesta U, Guruceaga X, Cendon-Sanchez S, et al. Nitrogen, iron, and zinc acquisition: key nutrients to Aspergillus fumigatus virulence. J Fungi. 2021;7(7):518.
   Web of Science ®Google Scholar
• Liebmann B, Muheisen TW, Muller M, et al. Deletion of the aspergillus fumigatus lysine biosynthesis gene lysF encoding homoaconitase leads to attenuated virulence in a low-dose mouse infection model of invasive aspergillosis. Arch Microbiol. 2004;181(5):378–383.
   PubMed Web of Science ®Google Scholar
• Ibrahim-Granet O, Dubourdeau M, Latgé J-P, et al. Methylcitrate synthase from aspergillus fumigatus is essential for manifestation of invasive aspergillosis. Cell Microbiol. 2007. DOI:10.1111/j.1462-5822.2007.01025.x
   Web of Science ®Google Scholar
• Misslinger M, Hortschansky P, Brakhage AA, et al. Fungal iron homeostasis with a focus on Aspergillus fumigatus. Biochim Biophys Acta, Mol Cell Res. 2021;1868(1):118885.
   PubMed Web of Science ®Google Scholar
• Fontaine T, Simenel C, Dubreucq G, et al. Molecular organization of the alkali-insoluble fraction of Aspergillus fumigatus cell wall. J Biol Chem. 2000;275(36):27594–27607.
   PubMed Web of Science ®Google Scholar
• Tsai HF, Chang YC, Washburn RG, et al. The developmentally regulated alb1 gene of Aspergillus fumigatus: its role in modulation of conidial morphology and virulence. J Bacteriol. 1998;180(12):3031–3038.
   PubMed Web of Science ®Google Scholar
• Lionakis MS, Lewis RE, May GS, et al. Toll-deficient Drosophila flies as a fast, high-throughput model for the study of antifungal drug efficacy against invasive aspergillosis and Aspergillus virulence. J Infect Dis. 2005;191(7):11881195.
   Web of Science ®Google Scholar
• Akoumianaki T, Kyrmizi I, Valsecchi I, et al. Aspergillus cell wall melanin blocks LC3- associated phagocytosis to promote pathogenicity. Cell Host & Microbe. 2016;19(1):79–90.
   PubMed Web of Science ®Google Scholar
• Brown NA, Goldman GH. The contribution of Aspergillus fumigatus stress responses to virulence and antifungal resistance. J Microbiol. 2016 Mar;54(3):243–253. DOI:10.1007/s12275-016-5510-4.
   PubMed Web of Science ®Google Scholar
• May GS. Mitogen-activated protein kinase pathways in Aspergilli. Genomics, Medical Aspects, Biotechnology, and Research Methods. 2008;121–127. DOI:10.1080/13693780400024784
   Google Scholar
• Ma D, Li R. Current understanding of HOG-MAPK pathway in Aspergillus fumigatus. Mycopathologia. 2013;175(1–2):13–23.
   PubMed Web of Science ®Google Scholar
• de Castro PA, Chen C, de Almeida RS, et al. ChIP-seq reveals a role for CrzA in the Aspergillus fumigatus high-osmolarity glycerol response (HOG) signalling pathway. Mol Microbiol. 2014;94(3):655–674.
   PubMed Web of Science ®Google Scholar
• Brown A, Cowen L, di Pietro A, et al. Stress Adaptation. Microbiol Spectr. 2017;5(4). DOI:10.1128/microbiolspec.FUNK-0048-2016
   Web of Science ®Google Scholar
• de Castro P, Chiaratto J, Winkelströter L, et al. The Involvement of the Mid1/Cch1/Yvc1 Calcium Channels in Aspergillus fumigatus Virulence. PLoS ONE. 2014;9(8):e103957.
   PubMed Web of Science ®Google Scholar
• Liu S, Hou Y, Liu W, et al. Components of the calcium-calcineurin signaling pathway in fungal cells and their potential as antifungal targets. Eukaryot Cell. 2015;14(4):324–334.
   PubMedGoogle Scholar
• Juvvadi PR, Lamoth F, Steinbach WJ. Calcineurin-mediated regulation of hyphal growth, septation, and virulence in Aspergillus fumigatus. Mycopathologia. 2014;178(5–6):341–348.
   PubMed Web of Science ®Google Scholar
• Krishnan K, Askew D. The fungal UPR. Virulence. 2013;5(2):334–340.
   PubMed Web of Science ®Google Scholar
• Askew D. Endoplasmic reticulum stress and fungal pathogenesis converge. Virulence. 2014;5(2):331–333.
   PubMed Web of Science ®Google Scholar
• Guirao-Abad JP, Weichert M, Albee A, et al. A human IRE1 inhibitor blocks the unfolded protein response in the pathogenic fungus aspergillus fumigatus and suggests noncanonical functions within the pathway. mSphere. 2020;5(5). DOI:10.1128/mSphere.00879-20
   PubMed Web of Science ®Google Scholar
• Wezensky S, Cramer R. Implications of hypoxic microenvironments during invasive aspergillosis. Med Mycol. 2011;49(S1):S120–124.
   PubMedGoogle Scholar
• Rius J, Guma M, Schachtrup C, et al. NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α. Nature. 2008;453(7196):807–811.
   PubMed Web of Science ®Google Scholar
• Ye Y, Chen Y, Sun J, et al. Hyperglycemia suppresses the regulatory effect of hypoxia-inducible factor-1α in pulmonary Aspergillus fumigatus infection. Pathog Dis. 2020;78(5). DOI:10.1093/femspd/ftaa038
   Web of Science ®Google Scholar
• Cunha C, Aversa F, Romani L, et al. Human Genetic Susceptibility to Invasive Aspergillosis. PLOS Pathogens. 2013;9(8):e1003434.
   PubMed Web of Science ®Google Scholar
• Kowalski C, Beattie S, Fuller K, et al. Heterogeneity among isolates reveals that fitness in low oxygen correlates with Aspergillus fumigatus virulence. MBio. 2016;7(5). DOI:10.1128/mBio.01515-16
   PubMed Web of Science ®Google Scholar
• Lupiañez C, Canet L, Carvalho A, et al. Polymorphisms in Host Immunity-Modulating Genes and Risk of Invasive Aspergillosis: results from the AspBIOmics Consortium. Infect Immun. 2016;84(3):643–657.
   Web of Science ®Google Scholar
• Brune K, Frank J, Schwingshackl A, et al. Pulmonary epithelial barrier function: some new players and mechanisms. Am J Physiol Lung Cell Mol Physiol. 2015;308(8):L731–745.
   PubMed Web of Science ®Google Scholar
• Ridley C, Thornton D. Mucins: the frontline defence of the lung. Biochem Soc Trans. 2018;46(5):1099–1106.
   PubMedGoogle Scholar
• Heinekamp T, Schmidt H, Lapp K, et al. Interference of Aspergillus fumigatus with the immune response. Semin Immunopathol. 2015;37(2):141–152.
   PubMed Web of Science ®Google Scholar
• Warwas M, Watson J, Bennet A, et al. Structure and role of sialic acids on the surface of Aspergillus fumigatus conidiospores. Glycobiology. 2007;17(4):401–410.
   PubMed Web of Science ®Google Scholar
• Jepsen C, Dubey L, Colmorten K, et al. FIBCD1 Binds Aspergillus fumigatus and regulates lung epithelial response to cell wall components. Front Immunol. 2018;9. DOI:10.3389/fimmu.2018.01967
   PubMed Web of Science ®Google Scholar
• Mambula S, Sau K, Henneke P, et al. Toll-like Receptor (TLR) Signaling in Response to Aspergillus fumigatus’. J Biol Chem. 2002;277(42):39320–39326.
   PubMed Web of Science ®Google Scholar
• Romani L. Immunity to fungal infections. Nat Rev Immunol. 2011;11(4):275–288.
   PubMed Web of Science ®Google Scholar
• Sun W, Lu X, Li X, et al. Dectin-1 is inducible and plays a crucial role in Aspergillus-induced innate immune responses in human bronchial epithelial cells. European Journal of Clinical Microbiology & Infectious Diseases. 2012;31(10):2755–2764.
   PubMed Web of Science ®Google Scholar
• Øya E, Becher R, Ekeren L, et al. Pro-inflammatory responses in human bronchial epithelial cells induced by spores and hyphal fragments of common damp indoor molds. Int J Environ Res Public Health. 2019;16(6):1085.
   PubMed Web of Science ®Google Scholar
• Drummond R, Brown G. The role of Dectin-1 in the host defence against fungal infections. Curr Opin Microbiol. 2011;14(4):392–399.
   PubMed Web of Science ®Google Scholar
• Zhao GQ, Lin J, Hu LT, et al. The role of Dectin-1/raf-1 signal cascade in innate immune of human corneal epithelial cells against Aspergillus fumigatus infection. Int J Ophthalmol. 2016;9(10):1371–1375.
   PubMed Web of Science ®Google Scholar
• Bidula S, Kenawy H, Ali Y, et al. Role of Ficolin-A and lectin complement pathway in the innate defense against pathogenic Aspergillus species. Infect Immun. 2013;81(5):1730–1740.
   PubMed Web of Science ®Google Scholar
• Khosravi A, Alheidary S, Nikaein D, et al. Aspergillus fumigatus conidia stimulate lung epithelial cells (TC-1 JHU-1) to produce IL-12, IFNγ, IL-13 and IL-17 cytokines: modulatory effect of propolis extract. Journal de Mycologie Médicale. 2018;28(4):594–598.
   PubMed Web of Science ®Google Scholar
• Beisswenger C, Hess C, Bals R. Aspergillus fumigatus conidia induce interferon- signalling in respiratory epithelial cells. Eur Respir J. 2011;39(2):411–418.
   PubMed Web of Science ®Google Scholar
• Mansour M, Tam J, Khan N, et al. Dectin-1 Activation controls maturation of β-1,3-glucan-containing phagosomes. J Biol Chem. 2013;288(22):16043–16054.
   PubMed Web of Science ®Google Scholar
• Bertuzzi M, Hayes G, Icheoku U, et al. Anti-Aspergillus activities of the respiratory epithelium in health and disease. J Fungi. 2018;4(1):8.
   Web of Science ®Google Scholar
• Han X, Yu R, Zhen D, et al. Β-1,3-Glucan-Induced Host Phospholipase D Activation is Involved in Aspergillus fumigatus Internalization into Type II Human Pneumocyte A549 Cells. PLoS ONE. 2011;6(7):e21468.
   PubMed Web of Science ®Google Scholar
• Bao Z, Han X, Chen F, et al. Evidence for the involvement of cofilin in Aspergillus fumigatus internalization into type II alveolar epithelial cells. BMC Microbiol. 2015;15(1). DOI:10.1186/s12866-015-0500-y
   Google Scholar
• Clark H, Powell A, Simmons K, et al. ‘Endocytic markers associated with the Internalization and Processing of Aspergillus fumigatus Conidia by BEAS-2B Cells. mSphere. 2019;4(1). DOI:10.1128/mSphere.00663-18
   PubMed Web of Science ®Google Scholar
• Wasylnka J, Moore M. Uptake of Aspergillus fumigatus Conidia by Phagocytic and Nonphagocytic Cells In Vitro: quantitation using strains expressing green fluorescent protein. Infect Immun. 2002;70(6):3156–3163.
   PubMed Web of Science ®Google Scholar
• Wasylnka J, Hissen A, Wan A, et al. Intracellular and extracellular growth of Aspergillus fumigatus. Med Mycol. 2005;43(s1):27–30.
   PubMedGoogle Scholar
• Schmidt H, Vlaic S, Krüger T, et al. Proteomics of Aspergillus fumigatus conidia-containing phagolysosomes identifies processes governing immune evasion. Molecular & Cellular Proteomics. 2018;17(6):1084–1096.
   PubMed Web of Science ®Google Scholar
• Seidel C, Moreno-Velásquez S, Ben-Ghazzi N, et al. Phagolysosomal survival enables non-lytic hyphal escape and ramification through lung epithelium during Aspergillus fumigatus Infection. Front Microbiol. 2020;11. DOI:10.3389/fmicb.2020.01955
   Web of Science ®Google Scholar
• Ben-Ghazzi N, Moreno-Velásquez S, Seidel C, et al. Characterisation of Aspergillus fumigatus endocytic trafficking within airway epithelial cells using high-resolution automated quantitative confocal microscopy. J Fungi. 2021;7(6):454.
   Web of Science ®Google Scholar
• Gross O, Poeck H, Bscheider M, et al. Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature. 2009;459(7245):433–436.
   PubMed Web of Science ®Google Scholar
• Bretz C, Gersuk G, Knoblaugh S, et al. MyD88 signaling contributes to early pulmonary responses to Aspergillus fumigatus. Infect Immun. 2008;76(3):952–958.
   PubMed Web of Science ®Google Scholar
• Deguine J, Barton G (2014) ‘MyD88: a central player in innate immune signaling’ F1000Prime Reports, 6. doi: 10.12703/P6-97
   Google Scholar
• Jhingran A, Kasahara S, Shepardson K, et al. Compartment-specific and sequential role of MyD88 and CARD9 in chemokine induction and innate defense during respiratory fungal infection. PLOS Pathogens. 2015;11(1):e1004589.
   PubMed Web of Science ®Google Scholar
• Jeong J, Lee K, Kim S, et al. Airway epithelial phosphoinositide 3-kinase-δ contributes to the modulation of fungi-induced innate immune response. Thorax. 2018;73(8):758–768.
   PubMed Web of Science ®Google Scholar
• Sun H, Xu X, Tian X, et al. Activation of NF-κB and respiratory burst following Aspergillus fumigatus stimulation of macrophages. Immunobiology. 2014;219(1):25–36.
   PubMed Web of Science ®Google Scholar
• Balloy V, Sallenave J, Wu Y, et al. Aspergillus fumigatus-induced Interleukin-8 synthesis by respiratory epithelial cells is controlled by the phosphatidylinositol 3-Kinase, p38 MAPK, and ERK1/2 Pathways and Not by the Toll-like Receptor-MyD88 Pathway. J Biol Chem. 2008;283(45):30513–30521.
   PubMed Web of Science ®Google Scholar
• Feldman M, Dutko R, Wood M, et al. Aspergillus fumigatus cell wall promotes apical airway epithelial recruitment of human neutrophils. Infect Immun. 2020;88(2). DOI:10.1128/IAI.00813-19
   PubMed Web of Science ®Google Scholar
• Kauffman H, Tomee J, van de Riet M, et al. Protease-dependent activation of epithelial cells by fungal allergens leads to morphologic changes and cytokine production. J Allergy Clin Immunol. 2000;105(6):1185–1193.
   PubMed Web of Science ®Google Scholar
• Watkins T, Liu H, Chung M, et al. Comparative transcriptomics of Aspergillus fumigatus strains upon exposure to human airway epithelial cells. Microb Genom. 2018;4(2). DOI:10.1099/mgen.0.000154
   PubMed Web of Science ®Google Scholar
• Rowley J, Namvar S, Gago S, et al. Differential proinflammatory Responses to Aspergillus fumigatus by airway epithelial cells in vitro are protease dependent. J Fungi. 2021;7(6):468.
   Web of Science ®Google Scholar
• Balenga N, Klichinsky M, Xie Z, et al. A fungal protease allergen provokes airway hyper-responsiveness in asthma. Nat Commun. 2015;6(1). DOI:10.1038/ncomms7763
   PubMedGoogle Scholar
• Namvar S, Warn P, Farnell E, et al. Aspergillus fumigatus proteases, Asp f 5 and Asp f 13, are essential for airway inflammation and remodelling in a murine inhalation model. Clinical & Experimental Allergy. 2015;45(5):982–993.
   PubMed Web of Science ®Google Scholar
• Wiesner D, Merkhofer R, Ober C, et al. Club cell TRPV4 serves as a damage sensor driving lung allergic inflammation. Cell Host & Microbe. 2020;27(4):614–628.e6.
   PubMed Web of Science ®Google Scholar
• Zhang C, Liu X, Chen F, et al. Gliotoxin destructs the pulmonary epithelium barrier function by reducing cofilin oligomer formation to promote the dissolution of actin stress fibers. Microbial Pathogenesis. 2018;123:169–176.
   PubMed Web of Science ®Google Scholar
• Stephens-Romero S, Mednick A, Feldmesser M. The pathogenesis of fatal outcome in murine pulmonary aspergillosis depends on the neutrophil depletion strategy. Infect Immun. 2005;73(1):114–125.
   PubMed Web of Science ®Google Scholar
• Mehrad B, Strieter RM, Moore TA, et al. CXC chemokine receptor-2 ligands are necessary components of neutrophil-mediated host defense in invasive pulmonary aspergillosis. Journal of Immunology (Baltimore. 1999;163(11):6086–6094. Md. : 1950 PMID: 10570298.
   PubMed Web of Science ®Google Scholar
• Caffrey A, Lehmann M, Zickovich J, et al. IL-1α signaling is critical for leukocyte recruitment after pulmonary Aspergillus fumigatus Challenge. PLOS Pathogens. 2015;11(1):e1004625.
   PubMed Web of Science ®Google Scholar
• Caffrey-Carr A, Hilmer K, Kowalski C, et al. Host-derived leukotriene B4 is critical for resistance against invasive pulmonary Aspergillosis. Front Immunol. 2018;8. DOI:10.3389/fimmu.2017.01984
   PubMed Web of Science ®Google Scholar
• Ralph B, Lehoux M, Ostapska H, et al. The IL-1 receptor is required to maintain neutrophil viability and function during Aspergillus fumigatus Airway Infection. Front Immunol. 2021;12. DOI:10.3389/fimmu.2021.675294.
   PubMed Web of Science ®Google Scholar
• Snarr B, St-Pierre G, Ralph B, et al. Galectin-3 enhances neutrophil motility and extravasation into the airways during Aspergillus fumigatus infection. PLOS Pathogens. 2020;16(8):e1008741.
   PubMed Web of Science ®Google Scholar
• Gazendam R, van Hamme J, Tool A, et al. Human neutrophils use different mechanisms to kill Aspergillus fumigatus Conidia and Hyphae: evidence from phagocyte defects. J Immunol. 2015;196(3):1272–1283.
   PubMed Web of Science ®Google Scholar
• Leal S, Vareechon C, Cowden S, et al. Fungal antioxidant pathways promote survival against neutrophils during infection. J Clin Investig. 2012;122(7):2482–2498.
   PubMed Web of Science ®Google Scholar
• Taylor P, Roy S, Leal S, et al. Activation of neutrophils by autocrine IL-17A–IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORγt and dectin-2. Nat Immunol. 2013;15(2):143–151.
   PubMed Web of Science ®Google Scholar
• Bellocchio S, Moretti S, Perruccio K, et al. Tlrs govern neutrophil activity in Aspergillosis. J Immunol. 2004;173(12):7406–7415.
   PubMed Web of Science ®Google Scholar
• Levitz S, Diamond R. Mechanisms of resistance of Aspergillus fumigatus conidia to killing by neutrophils in vitro. J Infect Dis. 1985;152(1):33–42.
   PubMed Web of Science ®Google Scholar
• Washburn R, Gallin J, Bennett J. Oxidative killing of Aspergillus fumigatus proceeds by parallel myeloperoxidase-dependent and -independent pathways. Infect Immun. 1987;55(9):2088–2092.
   PubMed Web of Science ®Google Scholar
• Tkalcevic J, Novelli M, Phylactides M, et al. Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G. Immunity. 2000;12(2):201–210.
   PubMed Web of Science ®Google Scholar
• Stergiopoulou T, Meletiadis J, Roilides E, et al. Host-dependent patterns of tissue injury in invasive pulmonary Aspergillosis. Am J Clin Pathol. 2007;127(3):349–355.
   PubMed Web of Science ®Google Scholar
• Guo Y, Kasahara S, Jhingran A, et al. During Aspergillus Infection, Monocyte-Derived DCs, Neutrophils, and Plasmacytoid DCs Enhance Innate Immune Defense through CXCR3-Dependent Crosstalk. Cell Host; Microbe. 2020;28(1):104–116.e4.
   PubMed Web of Science ®Google Scholar
• Espinosa V, Jhingran A, Dutta O, et al. Inflammatory monocytes orchestrate innate antifungal immunity in the lung. PLOS Pathogens. 2014;10(2):e1003940.
   PubMed Web of Science ®Google Scholar
• Espinosa V, Dutta O, McElrath C, et al. Type III interferon is a critical regulator of innate antifungal immunity. Sci Immunol. 2017;2(16). DOI:10.1126/sciimmunol.aan5357
   PubMed Web of Science ®Google Scholar
• Bruns S, Kniemeyer O, Hasenberg M, et al. Production of extracellular traps against Aspergillus fumigatus in Vitro and in infected lung tissue is dependent on invading neutrophils and influenced by hydrophobin rod. PLOS Pathogens. 2010;6(4):e1000873.
   PubMed Web of Science ®Google Scholar
• Niedźwiedzka-Rystwej P, Repka W, Tokarz-Deptuła B, et al. “In sickness and in health” – how neutrophil extracellular trap (NET) works in infections, selected diseases and pregnancy. J Inflam. 2019;16(1). DOI:10.1186/s12950-019-0222-2
   Google Scholar
• Urban C, Nett J. Neutrophil extracellular traps in fungal infection. Seminars in Cell & Developmental Biology. 2019;89:47–57.
   PubMed Web of Science ®Google Scholar
• Gray R. Nets in pneumonia: is just enough the right amount? Eur Respir J. 2018;51(4):1800619.
   PubMed Web of Science ®Google Scholar
• Bianchi M, Niemiec M, Siler U, et al. Restoration of anti-Aspergillus defense by neutrophil extracellular traps in human chronic granulomatous disease after gene therapy is calprotectin-dependent. J Allergy Clin Immunol. 2011;127(5):1243–1252.e7.
   PubMed Web of Science ®Google Scholar
• Silva J, Rodrigues N, Thompson‐souza G, et al. Mac‐1 Triggers neutrophil DNA extracellular trap formation to Aspergillus fumigatus independently of PAD4 histone citrullination. J Leukoc Biol. 2019;107(1):69–83.
   PubMed Web of Science ®Google Scholar
• McCormick A, Heesemann L, Wagener J, et al. Nets formed by human neutrophils inhibit growth of the pathogenic mold Aspergillus fumigatus. Microbes Infect. 2010;12(12–13):928–936.
   PubMed Web of Science ®Google Scholar
• Röhm M, Grimm M, D’auria A, et al. NADPH Oxidase promotes neutrophil extracellular trap formation in pulmonary aspergillosis. Infect Immun. 2014;82(5):1766–1777.
   PubMed Web of Science ®Google Scholar
• Byrne A, Mathie S, Gregory L, et al. Pulmonary macrophages: key players in the innate defence of the airways. Thorax. 2015;70(12):1189–1196.
   PubMed Web of Science ®Google Scholar
• Heung L. Monocytes and the host response to fungal pathogens. Front Cell Infect Microbiol. 2020;10:10.
   PubMed Web of Science ®Google Scholar
• Ibrahim-Granet O, Philippe B, Boleti H, et al. Phagocytosis and intracellular fate of Aspergillus fumigatus conidia in alveolar macrophages. Infect Immun. 2003;71(2):891–903.
   PubMed Web of Science ®Google Scholar
• Marr K, Koudadoust M, Black M, et al. Early events in macrophage killing of Aspergillus fumigatus Conidia: new flow cytometric viability assay. Clinical Diagnostic Laboratory Immunology. 2001;8(6):1240–1247.
   PubMedGoogle Scholar
• Philippe B, Ibrahim-Granet O, Prévost M, et al. Killing of Aspergillus fumigatus by alveolar macrophages is mediated by reactive oxidant Intermediates. Infect Immun. 2003;71(6):3034–3042.
   PubMed Web of Science ®Google Scholar
• Luther K, Torosantucci A, Brakhage A, et al. Phagocytosis of Aspergillus fumigatus conidia by murine macrophages involves recognition by the dectin-1 beta-glucan receptor and Toll-like receptor 2. Cell Microbiol. 2007;9(2):368–381.
   PubMed Web of Science ®Google Scholar
• Babior B, Kipnes R, Curnutte J. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Investig. 1973;52(3):741–744.
   PubMed Web of Science ®Google Scholar
• Forman H, Torres M. Reactive oxygen species and cell signaling. Am J Respir Crit Care Med. 2002;166(supplement_1):S4–8.
   PubMedGoogle Scholar
• Gersuk G, Underhill D, Zhu L, et al. Dectin-1 and TLRs permit macrophages to distinguish between different Aspergillus fumigatus Cellular States. J Immunol. 2006;176(6):3717–3724.
   PubMed Web of Science ®Google Scholar
• Grimm M, Vethanayagam R, Almyroudis N, et al. Monocyte- and macrophage-targeted NADPH oxidase mediates antifungal host defense and regulation of acute inflammation in mice. J Immunol. 2013;190(8):4175–4184.
   PubMed Web of Science ®Google Scholar
• Cornish E, Hurtgen B, McInnerney K, et al. Reduced nicotinamide adenine dinucleotide phosphate oxidase-independent resistance to Aspergillus fumigatus in alveolar macrophages. J Immunol. 2008;180(10):6854–6867.
   PubMed Web of Science ®Google Scholar
• Margalit A, Kavanagh K, Braus G. The innate immune response to Aspergillus fumigatus at the alveolar surface. FEMS Microbiol Rev. 2015;39(5):670–687.
   PubMed Web of Science ®Google Scholar
• Shekhova E, Silverman N. Mitochondrial reactive oxygen species as major effectors of antimicrobial immunity. PLOS Pathogens. 2020;16(5):e1008470.
   PubMed Web of Science ®Google Scholar
• Hatinguais R, Pradhan A, Brown G, et al. Mitochondrial reactive oxygen species regulate immune responses of macrophages to Aspergillus fumigatus. Front Immunol. 2021;12. DOI:10.3389/fimmu.2021.641495
   Web of Science ®Google Scholar
• Bhatia S, Fei M, Yarlagadda M, et al. Rapid host defense against Aspergillus fumigatus Involves alveolar macrophages with a predominance of alternatively activated phenotype. PLoS ONE. 2011;6(1):e15943.
   PubMed Web of Science ®Google Scholar
• Arango Duque G, Descoteaux A. Macrophage cytokines: involvement in immunity and infectious diseases. Front Immunol. 2014;5. DOI:10.3389/fimmu.2014.00491
   PubMed Web of Science ®Google Scholar
• Tracy M, Okorie C, Foley E, et al. Allergic Bronchopulmonary Aspergillosis. J Fungi. 2016;2(2):17.
   Google Scholar
• Parameswaran N, Patial S. Tumor necrosis factor-α signaling in macrophages. Crit Rev Eukaryot Gene Expr. 2010;20(2):87–103.
   PubMed Web of Science ®Google Scholar
• Jia X, Tang B, Zhu L, et al. CARD9 mediates Dectin-1–induced ERK activation by linking Ras-GRF1 to H-Ras for antifungal immunity. J Exp Med. 2014;211(11):2307–2321.
   PubMed Web of Science ®Google Scholar
• Lee D, Kim H. Innate immunity induced by fungal β-glucans via dectin-1 signaling pathway. Int J Med Mushrooms. 2014;16(1):1–16.
   PubMed Web of Science ®Google Scholar
• Valsecchi I, Lai J, Stephen-Victor E, et al. Assembly and disassembly of Aspergillus fumigatus conidial rodlets. The Cell Surface. 2019;5:100023.
   PubMedGoogle Scholar
• Chamilos G, Akoumianaki T, Kyrmizi I, et al. Melanin targets LC3-associated phagocytosis (LAP): a novel pathogenetic mechanism in fungal disease. Autophagy. 2016;12(5):888–889.
   PubMed Web of Science ®Google Scholar
• Akoumianaki T, Vaporidi K, Diamantaki E, et al. Uncoupling of IL-6 signaling and LC3-associated phagocytosis drives immunoparalysis during sepsis. Cell Host Microbe. 2021;29(8):1277–1293.e6.
   PubMed Web of Science ®Google Scholar
• Tam J, Mansour M, Khan N, et al. Dectin-1–dependent LC3 recruitment to phagosomes enhances fungicidal activity in macrophages. J Infect Dis. 2014;210(11):1844–1854.
   PubMed Web of Science ®Google Scholar
• Fatima N, Upadhyay T, Ahmad F, et al. Particulate β-glucan activates early and delayed phagosomal maturation and autophagy within macrophage in a NOX-2 dependent manner. Life Sci. 2021;266:118851.
   PubMed Web of Science ®Google Scholar
• Dubourdeau M, Athman R, Balloy V, et al. Aspergillus fumigatus induces innate immune responses in alveolar macrophages through the MAPK pathway independently of TLR2 and TLR4. J Immunol. 2006;177(6):3994–4001.
   PubMed Web of Science ®Google Scholar
• Shah A, Kannambath S, Herbst S, et al. Calcineurin orchestrates lateral transfer of Aspergillus fumigatus during macrophage cell death. Am J Respir Crit Care Med. 2016;194(9):1127–1139.
   PubMed Web of Science ®Google Scholar
• Gresnigt M, Jaeger M, Subbarao Malireddi R, et al. The absence of NOD1 enhances killing of Aspergillus fumigatus through modulation of dectin-1 Expression. Front Immunol. 2017;8. DOI:10.3389/fimmu.2017.01777
   PubMed Web of Science ®Google Scholar
• Wang X, Caffrey-Carr A, Liu K, et al. MDA5 is an essential sensor of a pathogen-associated molecular pattern associated with vitality that is necessary for host resistance against Aspergillus fumigatus’. J Immunol. 2020;205(11):3058–3070.
   PubMed Web of Science ®Google Scholar
• Wang X, Cunha C, Grau M, et al. MAVS expression in alveolar macrophages is essential for host resistance against Aspergillus fumigatus. J Immunol. 2022;209(2):346–353.
   PubMed Web of Science ®Google Scholar
• Bechman K, Galloway J, Winthrop K. Small-molecule protein kinases inhibitors and the risk of fungal infections. Current Fungal Infection Reports. 2019;13(4):229–243.
   Web of Science ®Google Scholar
• Kimmig L, Wu D, Gold M, et al. IL-6 inhibition in critically Ill COVID-19 patients is associated with increased secondary infections. Front Med (Lausanne). 2020;7. DOI:10.3389/fmed.2020.583897
   Web of Science ®Google Scholar
• Cunha C, Di Ianni M, Bozza S, et al. Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity. Blood. 2010;116(24):5394–5402.
   PubMed Web of Science ®Google Scholar
• Smith N, Bromley M, Denning D, et al. Elevated levels of the neutrophil chemoattractant pro–platelet basic protein in macrophages from individuals with chronic and allergic Aspergillosis. J Infect Dis. 2014;211(4):651–660.
   PubMed Web of Science ®Google Scholar
• Smith N, Hankinson J, Simpson A, et al. A prominent role for the IL1 pathway and IL15 in susceptibility to chronic cavitary pulmonary aspergillosis. Clin Microbiol Infect. 2014;20(8):O480–488.
   PubMed Web of Science ®Google Scholar
• Cunha C, Gonçalves S, Duarte-Oliveira C, et al. IL-10 overexpression predisposes to invasive aspergillosis by suppressing antifungal immunity. J Allergy Clin Immunol. 2017;140(3):867–870.e9.
   PubMed Web of Science ®Google Scholar
• Gresnigt M, Cunha C, Jaeger M, et al. Genetic deficiency of NOD2 confers resistance to invasive aspergillosis. Nat Commun. 2018;9(1). DOI:10.1038/s41467-018-04912-3
   Google Scholar
• Sueiro-Olivares M, Scott J, Gago S, et al. Fungal and host protein persulfidation are functionally correlated and modulate both virulence and antifungal response. PLoS Biol. 2021;19(6):e3001247.
   PubMed Web of Science ®Google Scholar
• Bozza S, Gaziano R, Spreca A, et al. Dendritic Cells transport conidia and hyphae of Aspergillus fumigatus from the airways to the draining lymph nodes and initiate disparate th responses to the fungus. J Immunol. 2002;168(3):1362–1371.
   PubMed Web of Science ®Google Scholar
• Serrano-Gómez D, Antonio Leal J, Corbí A. DC-SIGN mediates the binding of Aspergillus fumigatus and keratinophylic fungi by human dendritic cells. Immunobiology. 2005;210(2–4):175–183.
   PubMed Web of Science ®Google Scholar
• Gafa V, Lande R, Gagliardi M, et al. Human dendritic cells following Aspergillus fumigatus Infection Express the CCR7 receptor and a differential pattern of interleukin-12 (IL-12), IL-23, and IL-27 Cytokines, which lead to a Th1 response. Infect Immun. 2006;74(3):1480–1489.
   PubMed Web of Science ®Google Scholar
• Gafa V, Remoli M, Giacomini E, et al. In vitro infection of human dendritic cells by Aspergillus fumigatus conidia triggers the secretion of chemokines for neutrophil and Th1 lymphocyte recruitment. Microbes Infect. 2007;9(8):971–980.
   PubMed Web of Science ®Google Scholar
• Furlong-Silva J, Cook P, LeibundGut-Landmann S. Fungal-mediated lung allergic airway disease: the critical role of macrophages and dendritic cells. PLOS Pathogens. 2022;18(7):e1010608.
   PubMed Web of Science ®Google Scholar
• Zelante T, Wong A, Ping T, et al. CD103+ dendritic cells control Th17 cell function in the lung. Cell Rep. 2015;12(11):1789–1801.
   PubMed Web of Science ®Google Scholar
• Schlitzer A, McGovern N, Teo P, et al. IRF4 Transcription Factor-Dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses. Immunity. 2013;38(5):970–983.
   PubMed Web of Science ®Google Scholar
• Bozza S, Perruccio K, Montagnoli C, et al. A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation. Blood. 2003;102(10):3807–3814.
   PubMed Web of Science ®Google Scholar
• Bogorodskiy A, Bolkhovitina E, Gensch T, et al. Murine intraepithelial dendritic cells interact with phagocytic cells during Aspergillus fumigatus-induced inflammation. Front Immunol. 2020;11:11.
   PubMed Web of Science ®Google Scholar
• Loures F, Röhm M, Lee C, et al. Recognition of Aspergillus fumigatus hyphae by human plasmacytoid dendritic cells is mediated by Dectin-2 and Results in formation of extracellular traps. PLOS Pathogens. 2015;11(2):e1004643.
   PubMed Web of Science ®Google Scholar
• Ramirez-Ortiz Z, Lee C, Wang J, et al. A nonredundant role for plasmacytoid dendritic cells in host defense against the human fungal pathogen Aspergillus fumigatus. Cell Host & Microbe. 2011;9(5):415–424.
   PubMed Web of Science ®Google Scholar
• Park S, Burdick M, Brix W, et al. Neutropenia enhances lung dendritic cell recruitment in response to Aspergillus via a Cytokine-to-Chemokine amplification loop. J Immunol. 2010;185(10):6190–6197.
   PubMed Web of Science ®Google Scholar
• Rivera A, Hohl T, Collins N, et al. Dectin-1 diversifies Aspergillus fumigatus–specific T cell responses by inhibiting T helper type 1 CD4 T cell differentiation. J Exp Med. 2011;208(2):369–381.
   PubMed Web of Science ®Google Scholar
• Phadke A, Akangire G, Park S, et al. The role of CC Chemokine receptor 6 in host defense in a model of invasive pulmonary aspergillosis. Am J Respir Crit Care Med. 2007;175(11):1165–1172.
   PubMed Web of Science ®Google Scholar
• Braedel S, Radsak M, Einsele H, et al. Aspergillus fumigatus antigens activate innate immune cells via toll-like receptors 2 and 4. Br J Haematol. 2004;125(3):392–399.
   PubMed Web of Science ®Google Scholar
• Gafa V, Remoli M, Giacomini E, et al. Enhancement of anti-Aspergillus T helper type 1 response by interferon-β-conditioned dendritic cells. Immunology. 2010;131(2):282–288.
   PubMed Web of Science ®Google Scholar
• Morton C, Varga J, Hornbach A, et al. The temporal dynamics of differential gene expression in Aspergillus fumigatus Interacting with human immature dendritic cells in vitro. PLoS ONE. 2011;6(1):e16016.
   PubMed Web of Science ®Google Scholar
• Morton C, Fliesser M, Dittrich M, et al. Gene expression profiles of human dendritic cells interacting with Aspergillus fumigatus in a bilayer model of the alveolar epithelium/endothelium interface. PLoS ONE. 2014;9(5):e98279.
   PubMed Web of Science ®Google Scholar
• Veit G, Avramescu R, Chiang A, et al. From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations. ?Mol Biol Cell. 2016;27(3):424–433.
   Web of Science ®Google Scholar
• Saint-Criq V, Gray M. Role of CFTR in epithelial physiology. Cell Mol Life Sci. 2016;74(1):93–115.
   PubMed Web of Science ®Google Scholar
• Durie P, Kent G, Phillips M, et al. Characteristic multiorgan pathology of cystic fibrosis in a long-living cystic fibrosis transmembrane regulator knockout murine model. Am J Pathol. 2004;164(4):1481–1493.
   PubMed Web of Science ®Google Scholar
• Ooi C, Dorfman R, Cipolli M, et al. Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis. Gastroenterology. 2011;140(1):153–161.
   PubMed Web of Science ®Google Scholar
• Dupuis A, Keenan K, Ooi C, et al. Prevalence of meconium ileus marks the severity of mutations of the cystic fibrosis transmembrane conductance Regulator (CFTR) gene. Genet Med. 2016;18(4):333–340.
   PubMed Web of Science ®Google Scholar
• Marchand E, Delaunois L, Brancaleone P, et al. Frequency of cystic fibrosis transmembrane conductance regulator gene mutations and 5T allele in patients with allergic bronchopulmonary aspergillosis. Chest. 2001;119(3):762–767.
   PubMed Web of Science ®Google Scholar
• Hill D, Vasquez P, Mellnik J, et al. A biophysical basis for mucus solids concentration as a candidate biomarker for airways disease. PLoS ONE. 2014;9(2):e87681.
   PubMed Web of Science ®Google Scholar
• Rubin B, Thornton D. Dropping acid: why is cystic fibrosis mucus abnormal? Eur Respir J. 2018;52(6):1802057.
   PubMed Web of Science ®Google Scholar
• Turcios N. Cystic fibrosis lung disease: an overview. Respir Care. 2019;65(2):233–251.
   PubMed Web of Science ®Google Scholar
• Renders N, Verbrugh H, Van Belkum A. Dynamics of bacterial colonisation in the respiratory tract of patients with cystic fibrosis. Infect Genet Evol. 2001;1(1):29–39.
   PubMed Web of Science ®Google Scholar
• Coutinho H, Falcão-Silva V, Gonçalves G. Pulmonary bacterial pathogens in cystic fibrosis patients and antibiotic therapy: a tool for the health workers. International Archives of Medicine. 2008;1(1):24.
   PubMedGoogle Scholar
• Hector A, Chotirmall S, Lavelle G, et al. Chitinase activation in patients with fungus-associated cystic fibrosis lung disease. J Allergy Clin Immunol. 2016;138(4):1183–1189.e4.
   PubMed Web of Science ®Google Scholar
• Singh A, Ralhan A, Schwarz C, et al. Fungal Pathogens in CF airways: leave or treat? Mycopathologia. 2017;183(1):119–137.
   PubMed Web of Science ®Google Scholar
• Düesberg U, Wosniok J, Naehrlich L, et al. Risk factors for respiratory Aspergillus fumigatus in German cystic fibrosis patients and impact on lung function. Sci Rep. 2020;10(1). DOI:10.1038/s41598-020-75886-w
   PubMed Web of Science ®Google Scholar
• Soret P, Vandenborght L, Francis F, et al. Respiratory mycobiome and suggestion of inter-kingdom network during acute pulmonary exacerbation in cystic fibrosis. Sci Rep. 2020;10(1). DOI:10.1038/s41598-020-60015-4
   Web of Science ®Google Scholar
• Cuthbertson L, Felton I, James P, et al. The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasis. J Cystic Fibrosis. 2021;20(2):295–302.
   PubMed Web of Science ®Google Scholar
• Ross B, Lofgren L, Ashare A, et al. Aspergillus fumigatus In-Host HOG pathway mutation for cystic fibrosis lung microenvironment persistence. MBio. 2021;12(4). DOI:10.1128/mBio.02153-21
   Web of Science ®Google Scholar
• Engel T, Verweij P, van den Heuvel J, et al. Parasexual recombination enables Aspergillus fumigatus to persist in cystic fibrosis. ERJ Open Res. 2020;6(4):00020–2020.
   PubMedGoogle Scholar
• Burgel P, Paugam A, Hubert D, et al. Aspergillus fumigatus in the cystic fibrosis lung: pros and cons of azole therapy. Infect Drug Resist. 2016;9:229–238.
   PubMed Web of Science ®Google Scholar
• Hong G, Alby K, Ng S, et al. The presence of Aspergillus fumigatus is associated with worse respiratory quality of life in cystic fibrosis. J Cystic Fibrosis. 2020;19(1):125–130.
   PubMed Web of Science ®Google Scholar
• Mall M, Hartl D. CFTR: cystic fibrosis and beyond. Eur Respir J. 2014;44(4):1042–1054.
   PubMed Web of Science ®Google Scholar
• Inglis S, Corboz M, Ballard S. Effect of anion secretion inhibitors on mucin content of airway submucosal gland ducts. Am J Physiol Lung Cell Mol Physiol. 1998;274(5):L762–766.
   Web of Science ®Google Scholar
• Elborn S, Vallieres E. Cystic fibrosis gene mutations: evaluation and assessment of disease severity. Advances in Genomics and Genetics. 2014;161. DOI:10.2147/AGG.S53768
   Google Scholar
• Malhotra S, Hayes D, Wozniak D. Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface. Clinical Microbiology Reviews. 2019;32(3). DOI:10.1128/CMR.00138-18
   PubMed Web of Science ®Google Scholar
• Warris A, Bercusson A, Armstrong-James D. Aspergillus colonization and antifungal immunity in cystic fibrosis patients. Med Mycol. 2019;57(Supplement_2):S118–126.
   PubMedGoogle Scholar
• Matsui H, Grubb B, Tarran R, et al. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell. 1998;95(7):1005–1015.
   PubMed Web of Science ®Google Scholar
• Åstrand A, Hemmerling M, Root J, et al. Linking increased airway hydration, ciliary beating, and mucociliary clearance through ENaC inhibition. Am J Physiol Lung Cell Mol Physiol. 2015;308(1):L22–32.
   PubMed Web of Science ®Google Scholar
• Goldberg J, Pier G. The role of the CFTR in susceptibility to Pseudomonas aeruginosa infections in cystic fibrosis. Trends Microbiol. 2000;8(11):514–520.
   PubMed Web of Science ®Google Scholar
• Haq I, Gray M, Garnett J, et al. Airway surface liquid homeostasis in cystic fibrosis: pathophysiology and therapeutic targets. Thorax. 2015;71(3):284–287.
   PubMed Web of Science ®Google Scholar
• Coakley R, Grubb B, Paradiso A, et al. Abnormal surface liquid pH regulation by cultured cystic fibrosis bronchial epithelium. Proc Nat Acad Sci. 2003;100(26):16083–16088.
   PubMed Web of Science ®Google Scholar
• Abou Alaiwa M, Reznikov L, Gansemer N, et al. pH modulates the activity and synergism of the airway surface liquid antimicrobials β-defensin-3 and LL-37. Proc Nat Acad Sci. 2014;111(52):18703–18708.
   PubMed Web of Science ®Google Scholar
• Rehman T, Karp P, Tan P, et al. Inflammatory cytokines TNF-α and IL-17 enhance the efficacy of cystic fibrosis transmembrane conductance regulator modulators. J Clin Investig. 2021;131(16). DOI:10.1172/JCI150398
   PubMed Web of Science ®Google Scholar
• Smith J, Travis S, Greenberg E, et al. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell. 1996;85(2):229–236.
   PubMed Web of Science ®Google Scholar
• Pezzulo A, Tang X, Hoegger M, et al. Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung. Nature. 2012;487(7405):109–113.
   PubMed Web of Science ®Google Scholar
• Song Y, Salinas D, Nielson D, et al. Hyperacidity of secreted fluid from submucosal glands in early cystic fibrosis. Am J Physiol Cell Physiol. 2006;290(3):C741–749.
   PubMed Web of Science ®Google Scholar
• Hoegger M, Fischer A, McMenimen J, et al. Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis. Science. 2014;345(6198):818–822.
   PubMed Web of Science ®Google Scholar
• Caverly L, LiPuma J. Good cop, bad cop: anaerobes in cystic fibrosis airways. Eur Respir J. 2018;52(1):1801146.
   PubMed Web of Science ®Google Scholar
• Takuma T, Okada K, Uchida Y, et al. Invasive pulmonary aspergillosis resulting in respiratory failure during neutrophil recovery from postchemotherapy neutropenia in three patients with acute leukaemia. J Intern Med. 2002;252(2):173–177.
   PubMed Web of Science ®Google Scholar
• Grahl N, Puttikamonkul S, Macdonald J, et al. In vivo hypoxia and a fungal alcohol dehydrogenase influence the pathogenesis of invasive pulmonary aspergillosis. PLOS Pathogens. 2011;7(7):e1002145.
   PubMed Web of Science ®Google Scholar
• Gresnigt M, Rekiki A, Rasid O, et al. Reducing hypoxia and inflammation during invasive pulmonary aspergillosis by targeting the Interleukin-1 receptor. Sci Rep. 2016;6(1). DOI:10.1038/srep26490
   PubMedGoogle Scholar
• Bidula S, Schelenz S, Hogan DA. A sweet response to a sour situation: the role of soluble pattern recognition receptors in the innate immune response to invasive Aspergillus fumigatus Infections. PLOS Pathogens. 2016;12(7):e1005637.
   PubMed Web of Science ®Google Scholar
• Patin E, Thompson A, Orr S. Pattern recognition receptors in fungal immunity. Seminars in Cell & Developmental Biology. 2019;89:24–33.
   PubMed Web of Science ®Google Scholar
• Deban L, Jaillon S, Garlanda C, et al. Pentraxins in innate immunity: lessons from PTX3. Cell Tissue Res. 2011;343(1):237–249.
   PubMed Web of Science ®Google Scholar
• Kang Y, Yu Y, Lu L. The role of pentraxin 3 in Aspergillosis: reality and prospects. Mycobiology. 2020;48(1):1–8.
   PubMed Web of Science ®Google Scholar
• Garlanda C, Hirsch E, Bozza S, et al. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature. 2002;420(6912):182–186.
   PubMed Web of Science ®Google Scholar
• Bigot J, Guillot L, Guitard J, et al. Bronchial epithelial cells on the front line to fight lung infection-causing Aspergillus fumigatus. Front Immunol. 2020;11:11.
   PubMed Web of Science ®Google Scholar
• Bertuzzi M, Howell G, Thomson D, et al. Epithelial uptake of Aspergillus fumigatus drives efficient fungal clearance in vivo and is aberrant in Chronic Obstructive Pulmonary Disease (COPD). bioRxiv. 2022.
   Google Scholar
• Chaudhary N, Datta K, Askin FB, et al. Cystic fibrosis transmembrane conductance regulator regulates epithelial cell response to Aspergillus and resultant pulmonary inflammation. Am J Respir Crit Care Med. 2012;185(3):301–310.
   PubMed Web of Science ®Google Scholar
• Di A, Brown ME, Deriy LV, et al. CFTR regulates phagosome acidification in macrophages and alters bactericidal activity. Nat Cell Biol. 2006;8(9):933–944.
   PubMed Web of Science ®Google Scholar
• Law SM, Stanfield SJ, Hardisty GR, et al. Human cystic fibrosis monocyte derived macrophages display no defect in acidification of phagolysosomes when measured by optical nanosensors. J Cystic Fibrosis. 2020;19(2):203–210.
   PubMed Web of Science ®Google Scholar
• Wasylnka JA, Moore MM, Kozel TR. Adhesion of Aspergillus species to extracellular matrix proteins: evidence for involvement of negatively charged carbohydrates on the conidial surface. Infect Immun. 2000;68(6):3377–3384.
   PubMed Web of Science ®Google Scholar
• Bromley I, Donaldson K. Binding of Aspergillus fumigatus spores to lung epithelial cells and basement membrane proteins: relevance to the asthmatic lung. Thorax. 1996;51(12):1203–1209.
   PubMed Web of Science ®Google Scholar
• Frantz C, Stewart K, Weaver V. The extracellular matrix at a glance. J Cell Sci. 2010;123(24):4195–4200.
   PubMed Web of Science ®Google Scholar
• Gil M, Peñalver M, Lopez-Ribot J, et al. Binding of extracellular matrix proteins to Aspergillus fumigatus conidia. Infect Immun. 1996;64(12):5239–5247.
   PubMed Web of Science ®Google Scholar
• Ulrich M, Worlitzsch D, Viglio S, et al. Alveolar inflammation in cystic fibrosis. J Cyst Fibros. 2010;9(3):217–227.
   PubMed Web of Science ®Google Scholar
• Cowley A, Thornton D, Denning D, et al. Aspergillosis and the role of mucins in cystic fibrosis. Pediatr Pulmonol. 2016;52(4):548–555.
   PubMed Web of Science ®Google Scholar
• Dewi I, van de Veerdonk F, Gresnigt M. The multifaceted role of T-helper responses in host defense against Aspergillus fumigatus. J Fungi. 2017;3(4):55.
   Web of Science ®Google Scholar
• Beswick E, Amich J, Gago S. Factoring in the complexity of the cystic fibrosis lung to understand Aspergillus fumigatus and Pseudomonas aeruginosa Interactions. Pathogens. 2020;9(8):639.
   PubMed Web of Science ®Google Scholar
• Carsin A, Romain T, Ranque S, et al. Aspergillus fumigatus in cystic fibrosis: an update on immune interactions and molecular diagnostics in allergic bronchopulmonary aspergillosis. Allergy. 2017;72(11):1632–1642.
   PubMed Web of Science ®Google Scholar
• Müller C, Braag S, Herlihy J, et al. Enhanced IgE allergic response to Aspergillus fumigatus in CFTR−/− mice. Lab Invest. 2005;86(2):130–140.
   Web of Science ®Google Scholar
• Müller C, Braag S, Keeler A, et al. Lack of Cystic fibrosis transmembrane conductance regulator in CD3+Lymphocytes leads to aberrant cytokine secretion and hyperinflammatory adaptive immune responses. Am J Respir Cell Mol Biol. 2011;44(6):922–929.
   PubMed Web of Science ®Google Scholar
• Stolbrink M, Mortimer K. Collision of communicable and non-communicable disease epidemics—the case of HIV and COPD. Lancet Glob Health. 2018;6(2):e126–127.
   PubMed Web of Science ®Google Scholar
• Soriano J, Kendrick P, Paulson K, et al., . (2020) ‘Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017’, Lancet Respir Med, 8(6), pp.585–596. doi: 10.1016/S2213-2600(20)30105-3
   PubMed Web of Science ®Google Scholar
• Vestbo J, Hurd S, Agustí A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(4):347–365.
   PubMed Web of Science ®Google Scholar
• Bourdin A, Burgel P, Chanez P, et al. Recent advances in COPD: pathophysiology, respiratory physiology and clinical aspects, including comorbidities. Eur Respir Rev. 2009;18(114):198–212.
   PubMedGoogle Scholar
• Josephs L, Culliford D, Johnson M, et al. COPD overdiagnosis in primary care: a UK observational study of consistency of airflow obstruction. NPJ Prim Care Respir Med. 2019;29(1). DOI:10.1038/s41533-019-0145-7
   Google Scholar
• Patel I. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax. 2002;57(9):759–764.
   PubMed Web of Science ®Google Scholar
• Wang Z, Bafadhel M, Haldar K, et al. Lung microbiome dynamics in COPD exacerbations. Eur Respir J. 2016;47(4):1082–1092.
   PubMed Web of Science ®Google Scholar
• Leung J, Tiew P, Mac Aogáin M, et al. The role of acute and chronic respiratory colonization and infections in the pathogenesis of COPD. Respirology. 2017;22(4):634–650.
   PubMed Web of Science ®Google Scholar
• Barnes P. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138(1):16–27.
   PubMed Web of Science ®Google Scholar
• Imbert S, Bresler P, Boissonnas A, et al. Calcineurin inhibitors impair neutrophil activity against Aspergillus fumigatus in allogeneic hematopoietic stem cell transplant recipients. J Allergy Clin Immunol. 2016;138(3):860–868.
   PubMed Web of Science ®Google Scholar
• Jasper A, McIver W, Sapey E, et al. Understanding the role of neutrophils in chronic inflammatory airway disease. F1000res. 2019;8:557.
   Google Scholar
• Brightling C, Greening N. Airway inflammation in COPD: progress to precision medicine. Eur Respir J. 2019;54(2):1900651.
   PubMed Web of Science ®Google Scholar
• Lonergan M, Dicker A, Crichton M, et al. Blood neutrophil counts are associated with exacerbation frequency and mortality in COPD. Respir Res. 2020;21(1). DOI:10.1186/s12931-020-01436-7
   PubMed Web of Science ®Google Scholar
• Bafadhel M, Mckenna S, Agbetile J, et al. Aspergillus fumigatus during stable state and exacerbations of COPD. Eur Respir J. 2013;43(1):64–71.
   PubMed Web of Science ®Google Scholar
• Mircescu M, Lipuma L, van Rooijen N, et al. Essential role for neutrophils but not alveolar macrophages at early time points following Aspergillus fumigatus infection. J Infect Dis. 2009;200(4):647–656.
   PubMed Web of Science ®Google Scholar
• Rovina N, Koutsoukou A, Koulouris N. Inflammation and Immune Response in COPD: where Do We Stand? Mediators Inflamm. 2013;2013:1–9.
   Web of Science ®Google Scholar
• Faner R, Sobradillo P, Noguera A, et al. The inflammasome pathway in stable COPD and acute exacerbations. ERJ Open Res. 2016;2(3):00002–2016.
   PubMedGoogle Scholar
• Del Sero G. Antifungal type 1 responses are upregulated in IL-10-deficient mice. Microbes Infect. 1999;1(14):1169–1180.
   PubMed Web of Science ®Google Scholar
• van de Veerdonk F, Joosten L, Shaw P, et al. The inflammasome drives protective Th1 and Th17 cellular responses in disseminated candidiasis. Eur J Immunol. 2011;41(8):2260–2268.
   PubMed Web of Science ®Google Scholar
• Speakman E, Dambuza I, Salazar F, et al. T cell antifungal immunity and the role of C-Type Lectin Receptors. Trends Immunol. 2020;41(1):61–76.
   PubMed Web of Science ®Google Scholar
• Jolink H, de Boer R, Hombrink P, et al. Pulmonary immune responses against Aspergillus fumigatus are characterized by high frequencies of IL-17 producing T-cells. J Infect. 2017;74(1):81–88.
   PubMed Web of Science ®Google Scholar
• Mirkov I, El-Muzghi AA, Djokic J, et al. Pulmonary immune responses to Aspergillus fumigatus in rats. Biomedical Environ Sci. 2014;27(9):684–694.
   PubMed Web of Science ®Google Scholar
• Romani L, Fallarino F, De Luca A, et al. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature. 2008;451(7175):211–215.
   PubMed Web of Science ®Google Scholar
• Imani S, Salimian J, Fu J, et al. Th17/treg-related cytokine imbalance in sulfur mustard exposed and stable chronic obstructive pulmonary (COPD) patients: correlation with disease activity. Immunopharmacol Immunotoxicol. 2016;38(4):270–280.
   PubMed Web of Science ®Google Scholar
• Geng W, He H, Zhang Q, et al. Th17 cells are involved in mouse chronic obstructive pulmonary disease complicated with invasive pulmonary aspergillosis. Chinese Med J. 2020;134(5):555–563.
   PubMed Web of Science ®Google Scholar
• Lindén A, Andelid K, Tengvall S, et al. Systemic cytokine signaling via IL-17 in smokers with obstructive pulmonary disease: a link to bacterial colonization? Int J Chron Obstruct Pulmon Dis. 2015;689. DOI:10.2147/COPD.S76273
   PubMed Web of Science ®Google Scholar
• Everaerts S, Lagrou K, Vermeersch K, et al. Aspergillus fumigatus detection and risk factors in patients with COPD–Bronchiectasis overlap. Int J Mol Sci. 2018;19(2):523.
   PubMed Web of Science ®Google Scholar
• Aghapour M, Raee P, Moghaddam S, et al. Airway epithelial barrier dysfunction in chronic obstructive pulmonary disease: role of cigarette smoke exposure. Am J Respir Cell Mol Biol. 2018;58(2):157–169.
   PubMed Web of Science ®Google Scholar
• Heijink I, Noordhoek J, Timens W, et al. Abnormalities in airway epithelial junction formation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014;189(11):1439–1442.
   PubMed Web of Science ®Google Scholar
• Lababidi R, Cane J, Bafadhel M. Tight junction molecules are unresponsive in the epithelium of COPD patients during RV infection. Mechanisms of Lung Injury and Repair. 2021. DOI:10.1183/13993003.congress-2021.PA3619
   Google Scholar
• James A, Wenzel S. Clinical relevance of airway remodelling in airway diseases. Eur Respir J. 2007;30(1):134–155.
   PubMed Web of Science ®Google Scholar
• Namvar S, Labram B, Rowley J, et al. Aspergillus fumigatus—host Interactions mediating airway wall remodelling in asthma. J Fungi. 2022;8(2):159.
   Web of Science ®Google Scholar
• Hogg J, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(26):2645–2653.
   PubMed Web of Science ®Google Scholar
• Tian P, Wen F. Clinical significance of airway mucus hypersecretion in chronic obstructive pulmonary disease. J Transl Int Med. 2015;3(3):89–92.
   PubMedGoogle Scholar
• Shen Y, Huang S, Kang J, et al. Management of airway mucus hypersecretion in chronic airway inflammatory disease: Chinese expert consensus (English edition). Int J Chron Obstruct Pulmon Dis. 2018;13:399–407.
   PubMed Web of Science ®Google Scholar
• Wu X, Lee B, Zhu L, et al. Exposure to mold proteases stimulates mucin production in airway epithelial cells through Ras/Raf1/ERK signal pathway. PLoS ONE. 2020;15(4):e0231990.
   PubMed Web of Science ®Google Scholar
• Taccone F, Van den Abeele A, Bulpa P, et al. Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes. crit care. 2015;19(1). DOI:10.1186/s13054-014-0722-7
   Google Scholar
• Gu Y, Ye X, Liu Y, et al. A risk-predictive model for invasive pulmonary aspergillosis in patients with acute exacerbation of chronic obstructive pulmonary disease. Respir Res. 2021;22(1). DOI:10.1186/s12931-021-01771-3
   Web of Science ®Google Scholar
• Ng T, Robson G, Denning D. Hydrocortisone-enhanced growth of Aspergillus spp.: implications for pathogenesis. Microbiology. 1994;140(9):2475–2479.
   PubMedGoogle Scholar
• Gonçalves S, Lagrou K, Duarte-Oliveira C, et al. The microbiome-metabolome crosstalk in the pathogenesis of respiratory fungal diseases. Virulence. 2016;8(6):673–684.
   PubMed Web of Science ®Google Scholar
• Schauwvlieghe A, Rijnders B, Philips N, et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med. 2018;6(10):782–792.
   PubMed Web of Science ®Google Scholar
• Husni R, Gordon S, Longworth D, et al. Cytomegalovirus Infection is a Risk Factor for Invasive Aspergillosis in Lung Transplant Recipients. Clinl Infect Dis. 1998;26(3):753–755.
   PubMed Web of Science ®Google Scholar
• Alanio A, Dellière S, Fodil S, et al. Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19. Lancet Respir Med. 2020;8(6):e48–49.
   PubMed Web of Science ®Google Scholar
• Wauters J, Baar I, Meersseman P, et al. Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study. Intensive care Med. 2012;38(11):1761–1768.
   PubMed Web of Science ®Google Scholar
• Prattes J, Wauters J, Giacobbe D, et al. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European confederation of medical mycology. Clin Microbiol Infect. 2022;28(4):580–587.
   PubMed Web of Science ®Google Scholar
• Gold J, Ahmad F, Cisewski J, et al. Increased deaths from fungal infections during the COVID-19 pandemic—national vital statistics system, United States, January 2020–December 2021. Clinl Infect Dis. 2022. DOI:10.1093/cid/ciac489
   Web of Science ®Google Scholar
• Hoenigl M, Seidel D, Sprute R, et al. COVID-19-associated fungal infections. Nat Microbiol. 2022;7(8):1127–1140.
   PubMed Web of Science ®Google Scholar
• Manohar P, Loh B, Athira S, et al. Secondary bacterial infections during pulmonary viral disease: phage therapeutics as alternatives to antibiotics? Front Microbiol. 2020;11. DOI:10.3389/fmicb.2020.01434
   Web of Science ®Google Scholar
• Robinson K. Mechanistic basis of super-infection: influenza-associated invasive pulmonary Aspergillosis. J Fungi. 2022;8(5):428.
   Web of Science ®Google Scholar
• Tobin J, Nickolich K, Ramanan K, et al. Influenza suppresses neutrophil recruitment to the lung and exacerbates secondary invasive pulmonary Aspergillosis. J Immunol. 2020;205(2):480–488.
   PubMed Web of Science ®Google Scholar
• Seldeslachts L, Vanderbeke L, Fremau A, et al. Early oseltamivir reduces risk for influenza-associated aspergillosis in a double-hit murine model. Virulence. 2021;12(1):2493–2508.
   PubMed Web of Science ®Google Scholar
• Dewi I, Cunha C, Jaeger M, et al. Neuraminidase and SIGLEC15 modulate the host defense against pulmonary aspergillosis. Cell Reports Medicine. 2021;2(5):100289.
   PubMedGoogle Scholar
• Davido B, Lemarie B, Gault E, et al. Superinfection is associated with short-term outcome and mortality in viral respiratory tract infections during the fall-winter seasons 2016-2018 in the greater Paris area: the SUPERFLUOUS study. Inter J Infect Dis. 2022;119:217–224.
   PubMed Web of Science ®Google Scholar
• Rijnders B, Schauwvlieghe A, Wauters J. Influenza-associated pulmonary aspergillosis: a local or global lethal combination? Clinl Infect Dis. 2020;71(7):1764–1767.
   PubMed Web of Science ®Google Scholar
• Gago S, Denning D, Bowyer P. Pathophysiological aspects of Aspergillus colonization in disease. Med Mycol. 2018;57(Supplement_2):S219–227.
   Google Scholar
• Dancer P, Pickard A, Potocka W, et al. Mutual inhibition of airway epithelial responses supports viral and fungal co-pathogenesis during coinfection. bioRxiv. 2022 04 13:488236
   Google Scholar
• Seelbinder B, Wallstabe J, Marischen L, et al. Triple RNA-seq reveals synergy in a human virus-fungus co-infection model. Cell Rep. 2020;33(7):108389.
   PubMed Web of Science ®Google Scholar
• Nicolas de Lamballerie C, Pizzorno A, Fouret J, et al. Transcriptional profiling of immune and inflammatory responses in the context of SARS-CoV-2 fungal superinfection in a human airway epithelial model. Microorganisms. 2020;8(12):1974.
   PubMed Web of Science ®Google Scholar
• Gale M, Sen G. Viral Evasion of the Interferon System. Journal of Interferon & Cytokine Research. 2009;29(9):475–476.
   PubMed Web of Science ®Google Scholar
• Schulz K, Mossman K. Viral evasion strategies in type I IFN signaling – a summary of recent developments. Front Immunol. 2016;7. DOI:10.3389/fimmu.2016.00498
   PubMed Web of Science ®Google Scholar
• Cenci E, Mencacci A, Del Sero G, et al. Interleukin‐4 Causes susceptibility to invasive pulmonary aspergillosis through suppression of protective type I responses. J Infect Dis. 1999;180(6):1957–1968.
   PubMed Web of Science ®Google Scholar
• Delsing C, Gresnigt M, Leentjens J, et al. Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series. BMC Infect Dis. 2014;14(1). DOI:10.1186/1471-2334-14-166
   PubMedGoogle Scholar
• Hashimoto K, Graham B, Ho S, et al. Respiratory syncytial virus in allergic lung inflammation increases Muc5ac and Gob-5. Am J Respir Crit Care Med. 2004;170(3):306–312.
   PubMed Web of Science ®Google Scholar
• Hewson C, Haas J, Bartlett N, et al. Rhinovirus induces MUC5AC in a human infection model and in vitro via NF- B and EGFR pathways. Eur Respir J. 2010;36(6):1425–1435.
   PubMed Web of Science ®Google Scholar
• Pittet L, Hall-Stoodley L, Rutkowski M, et al. Influenza virus infection decreases tracheal mucociliary velocity and clearance of streptococcus pneumoniae. Am J Respir Cell Mol Biol. 2010;42(4):450–460.
   PubMed Web of Science ®Google Scholar
• de Bentzmann S, Tristan A, Etienne J, et al. Staphylococcus aureus isolates associated with necrotizing pneumonia bind to basement membrane type I and IV collagens and laminin. J Infect Dis. 2004;190(8):1506–1515.
   PubMed Web of Science ®Google Scholar
• Leng L, Cao R, Ma J, et al. Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samples. Signal Transduct Target Ther. 2020;5(1). DOI:10.1038/s41392-020-00355-9
   PubMed Web of Science ®Google Scholar
• Wang H, Ding Y, Li X, et al. Fatal aspergillosis in a patient with SARS who was treated with corticosteroids. N Engl J Med. 2003;349(5):507–508.
   PubMed Web of Science ®Google Scholar
• Rouzé A, Lemaitre E, Martin-Loeches I, et al., Voicu, F., Arrive. ‘Invasive pulmonary aspergillosis among intubated patients with SARS-CoV-2 or influenza pneumonia: a European multicenter comparative cohort study’, crit care. 2022;26(1). doi: 10.1186/s13054-021-03874-1
   Web of Science ®Google Scholar
• Brüggemann R, van de Veerdonk F, Verweij P. The challenge of managing COVID-19 associated pulmonary Aspergillosis. Clinl Infect Dis. 2020;73(11):e3615–3616.
   Web of Science ®Google Scholar
• Baron A, Hachem M, Tran Van Nhieu J, et al. Bronchoalveolar lavage in patients with COVID-19 with invasive mechanical ventilation for acute respiratory distress syndrome. Ann Am Thoracic Soc. 2021;18(4):723–726.
   PubMed Web of Science ®Google Scholar
• Williams D. Clinical Pharmacology of Corticosteroids. Respir Care. 2018;63(6):655–670.
   PubMed Web of Science ®Google Scholar
• Sterne J, Murthy S, Diaz J, et al. Association between administration of systemic corticosteroids and mortality among critically Ill patients with COVID-19. JAMA. 2020;324(13):1330.
   PubMed Web of Science ®Google Scholar
• Marta G, Lorena F, Laura M, et al. COVID-19-associated pulmonary aspergillosis in a tertiary hospital. J Fungi. 2022;8(2):97.
   Web of Science ®Google Scholar
• RECOVERY Group Collaborative. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384(8):693–704. doi: 10.1056/NEJMoa2021436.
   PubMed Web of Science ®Google Scholar
• Tappe B, Lauruschkat C, Strobel L, et al. COVID-19 patients share common, corticosteroid-independent features of impaired host immunity to pathogenic molds. Front Immunol. 2022;13. DOI:10.3389/fimmu.2022.954985
   PubMed Web of Science ®Google Scholar
• Salazar F, Bignell E, Brown GD, et al. Pathogenesis of Respiratory Viral and Fungal Coinfections. 2022 19;35(1):e0009421.
   Google Scholar
• Feys S, Gonçalves S, Khan M, et al. Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study. Lancet Respir Med. 2022;10(12):1147–1159.
   PubMed Web of Science ®Google Scholar